




























Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Kelly, F. J., & Fussell, J. C. (2017). Role of oxidative stress in cardiovascular disease outcomes following
exposure to ambient air pollution. Free Radical Biology and Medicine, 110, 345-367. DOI:
10.1016/j.freeradbiomed.2017.06.019
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 06. Nov. 2017
Contents lists available at ScienceDirect
Free Radical Biology and Medicine
journal homepage: www.elsevier.com/locate/freeradbiomed
Review article
Role of oxidative stress in cardiovascular disease outcomes following
exposure to ambient air pollution
Frank J. Kelly⁎, Julia C. Fussell
NIHR Health Protection Research Unit in Health Impact of Environmental Hazards, Facility of Life Sciences and Medicine, King’s College London, 150 Stamford Street,
London SE1 9NH, UK








A B S T R A C T
Exposure to ambient air pollution is associated with adverse cardiovascular outcomes. These are manifested
through several, likely overlapping, pathways including at the functional level, endothelial dysfunction,
atherosclerosis, pro-coagulation and alterations in autonomic nervous system balance and blood pressure. At
numerous points within each of these pathways, there is potential for cellular oxidative imbalances to occur. The
current review examines epidemiological, occupational and controlled exposure studies and research employing
healthy and diseased animal models, isolated organs and cell cultures in assessing the importance of the pro-
oxidant potential of air pollution in the development of cardiovascular disease outcomes. The collective body of
data provides evidence that oxidative stress (OS) is not only central to eliciting speciﬁc cardiac endpoints, but is
also implicated in modulating the risk of succumbing to cardiovascular disease, sensitivity to ischemia/re-
perfusion injury and the onset and progression of metabolic disease following ambient pollution exposure. To
add to this large research eﬀort conducted to date, further work is required to provide greater insight into areas
such as (a) whether an oxidative imbalance triggers and/or worsens the eﬀect and/or is representative of the
consequence of disease progression, (b) OS pathways and cardiac outcomes caused by individual pollutants
within air pollution mixtures, or as a consequence of inter-pollutant interactions and (c) potential protection
provided by nutritional supplements and/or pharmacological agents with antioxidant properties, in susceptible
populations residing in polluted urban cities.
1. Introduction
Exposure to ambient air pollution is associated with adverse cardi-
ovascular outcomes [1–4]. These are manifested through several, likely
overlapping, pathways including at the functional level, endothelial
dysfunction, atherosclerosis, pro-coagulant changes, alterations in au-
tonomic nervous system (ANS) balance and changes in blood pressure
(BP) [1]. At the molecular level, principal pathways involved in eli-
citing such eﬀects will depend upon the nature of the air pollutants (i.e.
particles plus their components versus gases). These include (a) the
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instigation of an inﬂammatory response within the alveoli, causing
secondary systemic inﬂammation via pulmonary and systemic oxidative
injury which, via pro-oxidative and/or proinﬂammatory mediators,
brings about or exacerbates cardiovascular responses [5]; (b) the
translocation of ultraﬁne and nanosize particles and/or particle con-
stituents (organic compounds, metals) across the alveolar membrane
into the systemic circulation possibly giving rise to direct interaction
and localized toxicity within the vascular endothelium and/or cardiac
tissue [6,7]; (c) the activation of airway sensitive receptors or nerves
and subsequent ANS imbalance [8]. At numerous points within each of
these functional and molecular pathways, there is potential for cellular
oxidative imbalances to occur [9]. Human studies encompassing con-
trolled, occupational, panel and cross-sectional analyses have detected
associations between exposure and biomarker molecules that are
formed by the action of oxidants on lipids (eg malondialdehyde [MDA],
8-isoprostane) or nucleic acids (eg 8-oxo-7,8-dihydro-2′-deox-
yguanosine [8-oxodGuo]) [10]. In addition, epidemiological studies
have examined the degree to which polymorphisms in antioxidant re-
lated genes modify cardiovascular responses to air pollution [11]. These
studies are in turn helping to translate research investigating potential
mechanistic pathways in healthy and diseased animal models, isolated
organs and cell cultures where evidence of a contributory role of OS in
the target tissue has been documented [12–14]. The use of diseased or
susceptible animal models (atherosclerosis, hypertension, diabetes) is
particularly useful in that in such circumstances, the cellular machinery
to elicit OS is already prepared if not operative.
In 2010 Brook and colleagues [1] presented persuasive evidence
that oxidative stress is a critically important cause and consequence of
PM-mediated cardiovascular eﬀects. The objective of this review is to
examine subsequent evidence that has assessed the importance of the
pro-oxidant potential of particulate and gaseous air pollution in the
development of cardiovascular disease outcomes. Apart from some key
earlier ﬁndings that are included for contextual background, the studies
selected for inclusion were collected through a PubMed search for ar-
ticles published between January 2009 to October 2016 using the fol-
lowing keywords: oxidative stress OR oxidative potential AND air pol-
lution OR PM OR ozone (O3) OR carbon monoxide (CO) OR nitrogen
dioxide (NO2) AND cardiovascular OR cardiovascular disease OR
myocardial OR heart OR cardiac OR stroke OR heart rate OR ar-
rhythmia OR heart rate variability OR autonomic OR sympathetic OR
atherosclerosis OR vascular OR blood pressure OR hypertension OR
diabetes OR metabolic OR thrombosis OR coagulation. Studies in-
vestigating the eﬀects of particulate air pollution encompass PM in
urban air, concentrated ambient particles (CAPs), diesel exhaust (DE)
and PM from DE, i.e. diesel exhaust particles (DEPs). Manufactured
nanoparticles are not included in this review. The titles and abstracts of
over 1300 original research and review articles were examined (in-
cluding studies that were identiﬁed from the reference lists of relevant
review articles stemming from the primary search results). Those that
were not relevant to the focus of this review were discarded, leaving
267 articles that were then appraised in detail. Of these, the studies that
have been included in this review are limited to those deemed to be
have produced results of special interest, thereby adding to our un-
derstanding of how OS contributes towards cardiovascular disease in-
duced by exposure to ambient air pollution.
2. Endothelial dysfunction
The endothelium forms a single layer of cells lining the inner surface
of blood vessels, thereby forming a natural interface between the vas-
cular wall and systemic circulation. By ensuring a quiescent vascular
blockade to inﬂammation, cellular proliferation and thrombosis, and
through the synthesis and release of active mediators, the endothelium
is a key player in regulating vasomotor function i.e. the ability of blood
vessels to dilate and contract. This is a complex process, involving a ﬁne
balance between biological mediators, of which one of the most
important is nitric oxide (NO), owing to its many protective functions
that include relaxation of underlying vascular smooth muscle to control
blood ﬂow through arteries and blood pressure, inhibition of smooth
muscle proliferation and remodeling, regulation of blood clotting and
inhibition of circulating inﬂammatory cells [15–17]. It is not surprising
therefore that abnormal endothelial function is one of the major path-
ways leading to pathological changes in the cardiovascular system as a
consequence of an array of perturbations including ﬁbrinolytic im-
balance, aggregation of platelets and subsequent thrombogenesis and
atheroma formation. In fact endothelial dysfunction is one of earliest
events in the formation of an atheroma and the magnitude of en-
dothelial dysfunction correlates with the extent of atherosclerosis [18].
Endothelial activation, characterized by increased inﬂammation, is an
early event in endothelial dysfunction and involves increased expres-
sion of intercellular adhesion molecule 1 (ICAM-1) and vascular cell
adhesion molecule 1 (VCAM-1). These adhesion molecules promote
monocyte adhesion onto the endothelium, their diﬀerentiation into
macrophages, migration to the intima and subsequent transformation to
lipid-laden foam cells [19–21]. The expression of ICAM-1 and VCAM-1
on endothelial cells is thus an early event in the development of
atherosclerosis.
Robust evidence demonstrates that vascular OS following ambient
pollution (particularly particulate) exposure is central in the patho-
genesis of endothelial-dependent vasomotor dysfunction (Table 1).
Endothelial dysfunction in association with OS can stem from the
production of the superoxide anion radical (O2*-) via activation of ni-
cotinamide adenine dinucleotide phosphate, reduced (NADPH) oxi-
dases that are widely distributed within the heart. The superoxide anion
radical promotes oxidative degradation of the essential NO synthase
cofactor, tetrahydrobiopterin (BH4), leading to uncoupling of en-
dothelial nitric oxide synthase (eNOS) and O2*- (rather than NO) gen-
eration [5,22]. Scavenging of NO by O2*- therefore not only generates
harmful peroxynitrite as a product of the reaction [23], but importantly
also leads to a compromise in the diverse actions of NO.
2.1. Human studies
To gain insight into relevant biological pathways for the association
between PM and adverse cardiovascular outcomes, Madrigano et al.
[24] examined the potential impact of antioxidant gene polymorphisms
on the relationship between black carbon (BC) and PM2.5 (particulate
matter less than 2.5 µm in diameter) exposure and serum concentra-
tions of soluble ICAM-1 (sICAM-1) and soluble VCAM-1 (sVCAM-1) in
809 participants of the Normative Aging Study. Whilst ambient PM2.5
concentrations were not associated with changes in sICAM-1 or sVCAM-
1, associations between BC and sVCAM were magniﬁed in subjects with
a glutathione S-transferase M1 (GSTM1) deletion. A genetic score ap-
proach, investigating interactions between relevant pathways and the
environment, also suggests that OS plays a role in the association of
ambient particles derived from oil combustion and endothelial dys-
function [25,26]. Research examining the association between PM
oxidative potential (OP; the capacity of particles to cause damaging
oxidative reactions) and adverse health outcomes is in its infancy, but a
cohort panel study in 93 elderly non-smoking adults suggests that short-
term exposures to traﬃc-related air pollutants with a high OP con-
tribute to microvascular endothelial dysfunction, represented by re-
active hyperemia index (RHI) [27] (Fig. 1). Finally in 12 healthy sub-
jects, acute (2 h) experimental exposure to DE (300 μg/m3 PM2.5), a
major component of near-road PM, impaired NO–mediated endothelial
vasomotor function and promoted O2*- production (lucigenin chemi-
luminescence) in human umbilical vein endothelial cells (HUVEC) pre-
incubated with serum from 5 of the subjects [28].
2.2. Animal studies
An OS pathway has also been implicated in vasomotor dysfunction
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Table 1
Studies linking air pollution exposure to endothelial dysfunction mediated by oxidative stress.
Human
Study [reference] Population/design Air pollutant Main ﬁndings
Madrigano et al. [24] 809 participants of NAS cohort Ambient PM2.5 and BC Association between ambient BC and sVCAM−1 modiﬁed
by GSTM1 deletion
Bind et al. [25] 922 participants of NAS cohort Ambient PM2.5 and BC Signiﬁcant associations between particle number and
ﬁbrinogen among participants with higher genetic scores
within OS pathway
Dai et al. [26] 712–739 participants of NAS
cohort
Ambient PM2.5 species & sources Associations between particles derived from oil
combustion & ICAM−1 and VCAM−1 might be stronger in
individuals with higher allelic risk proﬁles related to OS
Zhang et al. [27] 93 adults of an elderly cohort Ambient traﬃc-related pollutants Traﬃc-related air pollutants with high OP are major
components contributing to microvascular dysfunction
Wauters et al. [28] Randomized, controlled crossover
study in
12 healthy male adults
Ambient air or DE (300 μg/m3 PM2.5); 120 min DE impaired NO–mediated endothelial vasomotor function
(hyperemic provocative tests) & promoted O2*- generation
(lucigenin chemiluminescence) in endothelial cells
Animal
Study [reference] Animal model Air pollutant exposure Main ﬁndings (exposed versus control)
Cherng et al. [22] Sprague-Dawley rats DE (300 μg/m3 PM); 5 h Impaired Ach-mediated relaxation and increased O2*-
(DHT) in coronary arteries of rats; signals blocked with O2*-
scavenging, NOS inhibition or BH4 supplementation
Ying et al. [29] ApoE−/− mice Concentrated ambient PM2.5 plus nickel
(66.5± 44.6 μg/m3); 6 h/d, 5 d/ week for 3mo
Increased aortic contractile response and systemic OS
(increased plasma 8-isoprostane) and decreased eNOS
dimers in the aorta. Eﬀects on NOS monomer formation in
cultured endothelial cells attenuated by Tiron
Kampfrath et al. [30] Balb/c (TLR4wt) and Tlr4Lps-d
(TLR4d, background strain BALB/
cAnPt)
CAP exposure (92.4 μg/m3); 6 h/d, 5 d/wk for
20wk
Impaired aortic tonal responses and induction of NADPH
oxidase-derived O2*- (lucigenin chemiluminescence) in
monocytes, aortic tissue and perivascular fat mediated by
TLR 4
Lund et al. [31] ApoE−/− mice GEE (60 μg/m3); 6 h/d for 7d Increased production of aortic lipid peroxidation (TBARS)
and O2*- (DHT staining); aortic upregulation of MMP−2,
MMP−9, TIMP−2, ET−1 mediated in part through
activation of ETA
Lund et al. [32] ApoE−/− mice Mixed vehicle exhaust (250 μg/m3 PM diesel plus
50 μg/m3 PM GE); 6 h/d for 7d
Increased production of aortic lipid peroxidation (TBARS)
and O2*- (DHT staining); aortic upregulation of MM−9 and
ET−1 mRNA expression, mediated in part through
activation of LOX−1
Labranche et al. [33] Normotensive Wistar or SH rats IT DEP (0.8 mg) 3x/wk for 4 wk Impaired Ach-induced relaxations and upregulation of
p22phox in aortas in the SHRs only
Li et al. [34] Wistar rats NO2 (5–20 mg/m3) 6 h/d for 7 d Decreased Cu/Zn-SOD activity, increased Mn-SOD and GPx
activity, increased MDA and PCO and upregulation of
ET−1
Chuang et al. [35] C57Bl/6 mice O3 (0.5 ppm) 8 h/d for 5 or 5d Decreased aortic SOD activity, eNOS protein and indices of
NO production
Kodavanti et al. [36] Wistar rats O3 (0.4 ppm) or DEP (2.1 mg/m3); 5 h/day, 1 day/
week for 16 weeks
Increased aortic (but not heart) HO−1, ET−1, ETA, ETB,
eNOS, TF, PAI−1, tPA, vWF, MMP−2, MMP−3, and
TIMP−2
Paﬀett et al. [37] Sprague-Dawley rats O3 (1 ppm) 4 h Diminished dilatory response of coronary vascular bed to
Ach, restored to diﬀerent degrees by SOD, CAT and NADPH
oxidase inhibition
Cui et al. [40] C57BL/6 mice Intranasal PM (10 μg) 3x/wk for 1 m Reduced BMSC population, increased DCFH-DA oxidation,
decreased p-AKT
Cui et al. [41] C57BL/6 mice Intranasal PM (10 μg) 3x/wk for 1 m Decreased circulating EPC population, increased DCFH-DA
oxidation; treatment with NAC or use of a transgenic model
with overexpression of the antioxidant enzyme network
eﬀectively prevented eﬀects
In vitro
Study [reference] Cells/tissue Air pollutant exposure Main ﬁndings (exposed versus control)
Li et al. [48] HAEC UF DEPs (50 μg/ml) Dose-dependent induction of OS (increased cytosolic and
mitochondrial O2*- production and expression of HO−1)
via JNK activation
Mo et al. [50] MPMVEC UFP (10–100 μg/ml) NADPH is major source of oxidants generated, involving
the translocation of p47phox, p67phox and rac 1 to plasma
membrane
Forchhammer et al. [43] HUVEC Wood smoke particles (1–100 μg/ml) Increased VCAM- 1 expression (1 μg/ml); THP−1
monocyte adhesion (50 or 100 μg/ml); unchanged
intracellular production of DCFH-DA oxidation
Cao et al. [46] HUVEC CB (100 μg/ml) DCFH-DA oxidation; increased VCAM−1 and ICAM−1
(continued on next page)
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observed in animals following exposure to particulate air pollution.
Acute DE (300 μg/m3 PM, 5 h) inhalation impairs acetylcholine (Ach)-
mediated relaxation and increases O2*- production (dihydroethidium
[DHT] staining) in coronary arteries of rats, signals that were blocked
with O2*- scavenging, NOS inhibition or BH4 supplementation [22].
Further evidence of NOS uncoupling comes from a murine 3-month
nickel (Ni) plus CAP exposure by Ying et al. [29], which induced en-
dothelial dysfunction, systemic OS (increased plasma 8-isoprostane)
and a redox-dependent decrease in eNOS dimers in the aorta, as evi-
denced by reversal of the eﬀect by the antioxidant Tiron in cultured
endothelial cells. The same researchers demonstrated that impaired
aortic tonal responses and induction of NADPH oxidase-derived O2*-
(lucigenin chemiluminescence) in monocytes, aortic tissue and peri-
vascular fat of mice following chronic CAP exposure (92.4 μg/m3, 6 h/
d, 5 d/wk for 20 weeks) is mediated by Toll like receptor 4 [30]. Oxi-
dative stress following exposure to vehicular source air pollutants has
been implicated in the imbalance of vasoactive factors produced by the
endothelium. A 7-day exposure to gasoline engine exhaust (GEE; 60 μg/
m3, 6 h/d) or mixed vehicle exhaust (250 μg/m3 PM diesel plus 50 μg/
m3 PM gasoline exhaust) was associated with increased production of
lipid peroxides (TBARS) and O2*- (DHT staining) in the aorta of ApoE-/-
mice along with an upregulation of circulating and vascular factors
(matrix metalloproteinase [MMP]−2, MMP-9, tissue inhibitor of me-
talloproteinases [TIMP]−2, ET-1) mediated in part through activation
of ET-1-endothelial receptor A (ETA) and lectin-like oxidized low-den-
sity lipoprotein (LOX-1) receptor pathways [31,32]. LOX-1 is the major
endothelial cell-surface receptor responsible for macrophage binding
and internalization of oxidized low-density lipoprotein (oxLDL). Of
interest, when normotensive and spontaneously hypertensive (SH) rats
were exposed via intratracheal (IT) instillation to DEP for 4 weeks
(0.8 mg, 3 times a week for 4 weeks), impaired Ach-induced relaxa-
tions, accompanied with a signiﬁcant upregulation of the p22phox
NADPH oxidative component in aortas, were only observed in the SH
rat group, suggesting a possible synergism between DEP-induced
oxidative stress and classical risk factors [33].
Endothelial dysfunction accompanied by OS in animals exposed to
gaseous pollutants has also been reported [34–37]. High concentrations
of NO2 (5–20 mg/m3, 6 h/d for 7 days) produced mild pathology in the
heart of rats, and marked OS (reduction/induction of Cu/Zn-superoxide
dismutase [SOD], Mn-SOD and glutathione peroxidase [GPx] activity
and increased MDA and protein carbonyl [PCO]) along with an upre-
gulation of the vasoconstrictor ET-1 [34]. Subchronic (0.5 ppm for 1 or
5 days, 8 h/day) O3 exposure has also been shown to decrease SOD
activity, eNOS protein and indices of NO production in the mouse aorta
[35]. Following weekly episodic (5 h/day, 1 day/week for 16 weeks)
exposure of rats to either O3 (0.4 ppm) or DEP (2.1 mg/m3), mRNA
biomarkers of OS (hemeoxygenase-1 [HO-1], vasoconstriction (ET-1,
ETA, ETB, eNOS) and proteolysis (MMP-2, MMP-3, and TIMP-2) were
increased in the aorta, but not in the heart [36]. Twenty-four hours
following a single inhalation of 1 ppm O3, the coronary vascular bed of
rats exhibited a markedly diminished dilatory response to Ach, which
was restored to diﬀerent degrees by SOD, catalase (CAT) and NADPH
oxidase inhibition [37].
PM exposure also suppresses the number and function of bone
marrow-derived endothelial progenitor cells (EPCs) [38,39]. Moreover,
early research in this area suggests a mechanism related to an increased
level of oxidants [40,41]. PM treated (as low as 10 μg 3 times per week
for 1 month via intranasal instillation) mice exhibit a reduced bone
marrow stem cell (BMSC) population in association with increased di-
chlorodihydroﬂuorescein diacetate (DCFH-DA) oxidation, decreased
phosphorylated protein kinase B (p-AKT) and inhibited proliferation of
BMSCs without induction of apoptosis [40]. The exposure also de-
creased the circulating EPC population and promoted apoptosis of EPCs
in association with increased oxidant production, again detected using
the DCFH-DA probe [41]. Treatment with the thiol antioxidant N-
acetylcysteine (NAC) or use of a transgenic model with overexpression
of the antioxidant enzyme network eﬀectively prevented these eﬀects.
Table 1 (continued)
In vitro
Study [reference] Cells/tissue Air pollutant exposure Main ﬁndings (exposed versus control)
expression unaﬀected by BSO pre-treatment
Frikke-Schmidt et al. [51] HUVEC CB (50–100 μg/ml) and DEP (10–100 μg/ml) DCFH-DA oxidation and oxidatively damaged DNA;
increased VCAM−1 and ICAM−1 expression attenuated
by desferrioxamine but not vitamin C
Rui et al. [47] HUVEC PM2.5 (25–200 μg/ml) NAC prevented increased oxidant generation, attenuated
phosphorylation of JNK, ERK1/2, p38 MAPK and AKT,
decreased NF-κB activation and expression of ICAM−1 and
VCAM−1
Du et al. [49] HAEC UFP (12.5–50 μg/ml) Reduced NO production; increased eNOS S-
glutathionylation; UFP-mediated reduction in NO
production restored in the presence of JNK and NADPH
oxidase inhibitors NAC and SOD mimetics
Miller et al. [5] Isolated rat aortic rings DEP (10–100 μg/ml) Increased O2*- production, inhibition of endothelium-
dependent NO-mediated relaxation; eﬀects reversed in the
presence of SOD
Labranche et al. [33] isolated rat aortic rings DEP (100 μg/ml) Inhibited relaxations to Ach reversed in the presence of
SOD
Tseng et al. [53] HUVEC tube cells DEP (10 and 100 μg/ml) H2O2 production and release of TNF-α& IL−6 suppressed
by NAC through increased endogenous glutathione
Ach: acetylcholine; BMSC: bone marrow stem cell; BSO: buthionine sulphoximine; CAT: catalase; CB: carbon black; CAP: concentrated ambient particle; DCFH-DA: dichlorodihydro-
ﬂuorescein diacetate; DEP: diesel exhaust particle; DHT: dihydroethidium; eNOS: endothelial nitric oxide synthase; EPC: endothelial progenitor cell; ERK1/2: extracellular signal-
regulated kinase; ET-1: endothelin-1; ETA: ET-1-endothelial receptor A; GEE: gasoline engine exhaust; GPx: glutathione peroxidase; GSTM1: glutathione S-transferase-M1; H2O2: hydrogen
peroxide; HAEC: human aortic endothelial cell; HO-1: hemeoxygenase-1; HUVEC: human umbilical vein endothelial cell; ICAM-1: intercellular adhesion molecule 1; IL-6: interleukin-6;
IT: intratracheal; JNK: c-Jun NH2-terminal kinases; LOX-1: lectin-like oxidized low-density lipoprotein; MAPK: mitogen activated kinase; MMP: matrix metalloprotease; MPMVEC:
microvascular endothelial cell; NAC: N-acetylcysteine; NADPH: nicotinamide adenine dinucleotide phosphate, reduced; NAS: Normative Ageing Study; NO: nitric oxide; NO2: nitrogen
dioxide; NOS: nitric oxide synthase; O3: ozone; OP: oxidative potential; OS: oxidative stress; O2*-:superoxide anion radical; PAI-1: plasminogen activator inhibitor-1; p-AKT: phos-
phorylated protein kinase B; PM: particulate matter; PM2.5: particulate matter less than 2.5 µm in diameter; SH: spontaneously hypertensive; SOD: superoxide dismutase; sICAM-1: soluble
ICAM-1; sVCAM-1: soluble VCAM-1; TLR: Toll-like receptor; TF: tissue factor; TIMP-2: tissue inhibitor of matrix metalloprotease-2; TNF-α: tumor necrosis factor-α; tPA: tissue plas-
minogen activator; UF: ultraﬁne; UFP: ultraﬁne particle; UCAP: concentrated ambient ultraﬁne particle; VCAM-1: vascular cell adhesion molecule; vWF: von Willebrand factor.
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2.3. In vitro studies
Cell culture work with end points encompassing cell activation,
altered expression and production of messenger molecules and NO are
shedding further light on the mechanism by which various sources of
particulate air pollution induce OS and subsequent dysfunction in
vascular endothelial cells [42–50]. Ultraﬁne particles emitted from
diesel engines have been shown to dose-dependently induce OS (in-
creased cytosolic and mitochondrial O2*- production and expression of
HO-1) via c-Jun NH2-terminal kinases (JNK) activation in HAEC [48],
whilst in mouse pulmonary microvascular endothelial cells (MPMVEC),
NADPH has been demonstrated to be the major source of oxidants
generated (DCFH-DA oxidation) following ambient UFP exposure, in-
volving the translocation of the cytosolic proteins p47phox, p67phox
and rac 1 to the plasma membrane [50]. On investigating the sub-
sequent activation of endothelial cells by UFP-induced oxidants, these
investigators demonstrated that this was mediated through phosphor-
ylation of p38 mitogen activated kinase (MAPK) and extracellular
signal-regulated kinase (ERK1/2). The role of particulate-generated-
oxidants in the increased expression of ICAM-1 and VCAM-1 as well as
promoted adhesion of monocytes onto endothelial cells has also been
investigated [43,46,47,51,52]. Wood smoke particles (1 μg/ml) in-
creased VCAM- 1 expression on HUVECs and at 50 or 100 μg/ml caused
adhesion of THP-1 monocytes without having any eﬀect on DCFH-DA
oxidation [43]. Although increased oxidants were observed in HUVECs
after exposure to DEP and CB nanoparticles, results from inhibitor
studies indicate that this is not a prerequisite for increased adhesion
factor expression and foam cell formation, [46,51]. However using NAC
and selective kinases inhibitors, Rui et al. [47] demonstrated that
PM2.5-induced increase in intracellular oxidants generation triggers the
cell surface expression of ICAM-1 and VCAM-1 and adhesion of THP-1
cells to HUVECs through JNK, ERK1/2, p38 MAPK and AKT phos-
phorylation, and nuclear translocation of NF-κB in human EA.hy926
cells in a dose- and time- dependent manner. Oxidative stress has also
been implicated in an alternative mechanism underlying the regulation
of eNOS activity by ambient UFP, namely particulate pollutant-induced
increase in glutathione oxidation, protein S-glutathionylation, and
eNOS S-glutathionylation, leading to a decrease in NO production [49].
In that the UFP-mediated reduction in NO production was restored in
the presence of JNK and NADPH oxidase inhibitors, NAC and SOD
mimetics, supports the previous reports that UFP induced vascular OS
via NADPH oxidase and JNK activation [48,50]. Investigations into the
mechanisms behind vascular permeability exerted by DEP, using an
endothelial tube model, has also identiﬁed the importance of OS. This is
accompanied by the release of pro-inﬂammatory tumor necrosis factor
(TNF)-α and interleukin (IL)−6 from tube cells, subsequently stimu-
lating the secretion of vascular endothelial growth factor (VEGF)-A – a
cascade of events that could result in the disruption cell-cell borders
and increase vasculature permeability [53]. Exposure of isolated rat
aortic rings (thereby ruling out prior interaction with the lung or vas-
cular tissue) to DEP (10–100 μg/ml) generates O2*- and inhibits en-
dothelium-dependent NO-mediated relaxation, whilst these eﬀects are
reversed in the presence of SOD [5,33].
3. Atherosclerosis
Atherosclerosis is a progressive disease of the vasculature, char-
acterized by accumulation of lipids and ﬁbrous material (athero-
sclerotic plaques) within arteries over a prolonged period of time [54].
An early event in atherogenesis is endothelial cell injury described in
the previous section and with that, increased expression of adhesion
molecules and secretion of chemoattractant cytokines that induce
monocyte attachment and migration into the intima and sub-en-
dothelial space respectively [20,21]. Monocyte diﬀerentiation into
macrophages ensues and with that, engulfment of normal and oxo-LDL,
primarily mediated by CD36 (also known as oxoLDL receptor), a mac-
rophage scavenger receptor [55]. The oxidative modiﬁcation of LDL
accelerates uptake by macrophages and in doing so promotes the for-
mation of lipid-laden foam cells – the landmark in the development of
atherosclerosis. These progenitor lesions eventually develop into
atherosclerotic plaques as a consequence of further uptake of LDL,
smooth muscle cell proliferation and the development of a collagenous
ﬁbrous cap [20,21,56]. The presence of advanced lesions leads to a
narrowing of the artery, resulting in reduced blood ﬂow to tissues
(ischemia). Moreover, the plaques can become unstable and rupture,
leading to onset of myocardial infarction or stroke.
The biological pathways involved in atherosclerosis following ex-
posure to air pollution are undoubtedly complex, dependent upon
various cell types and an array of molecular mediators related to coa-
gulation, blood lipids, inﬂammation and OS. Indeed, the observation of
increased oxidants in many types of endothelial cells makes OS a key
candidate for initiating atheroma development following cellular dys-
function. In the sections that follow, evidence of contributory eﬀects,
such as enhancing, through oxidation, the pro-atherogenic properties of
LDLs and plaque vulnerability and diminishing the anti-atherogenic
function of protective high-density lipoproteins HDL(s), are described
(Table 2). Measures of oxidation in circulating blood are highly relevant
since they imply the involvement of oxidatively modiﬁed plasma LDL
and/or HDL, key players in the promotion or protection from athero-
sclerosis, respectively [57].
3.1. Human studies
A panel of 40 healthy university students relocating between two
Fig. 1. Association of microvascular function with a one interquartile range increase of
ambient and personal pollutants.Exposures were averaged across 1 day, 3 days, 5 days,
and 7 days preceding each subject’s reactive hyperemia index (RHI) measurement (A) and
the PM components in three diﬀerent size-fractions for exposures averaged across 5 days
preceding each subject’s RHI measurement (B). BC: black carbon; DTT: dithiothreitol; EC:
elemental carbon; OA: Organic acids; OC: organic carbon; PAHs: polycyclic aromatic
hydrocarbons; PM particulate matter; ROS: reactive oxygen species; WS: water-
soluble.Reproduced from Environmental Health (Zhang et al. [27]) (http://
creativecommons.org/licenses/by/4.0/).
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campuses with diﬀerent air pollution scenarios in Beijing, China pro-
vides evidence that certain PM2.5 chemical constituents/pollution
sources are more closely associated with changes in biomarkers of OS
associated with atherosclerosis [58]. Whilst PM2.5 iron and Ni and
PM2.5 from traﬃc emissions and coal combustions were positively as-
sociated with ox-LDL, calcium was associated with an increase in so-
luble CD36. Other studies examining the relationship between air pol-
lution exposure and OS, as indicated by higher levels of plasma ox-LDL,
have also found positive associations in occupationally exposed in-
dividuals, patients with diabetes and children [48,59–61]. The study by
Brucker et al [61] reported increased urinary 1-hydroxypyrene (1-OHP;
a biomarker of exposure to polycyclic aromatic hydrocarbons [PAHs]
from traﬃc emissions) levels in taxi drivers that were positively cor-
related with ox-LDL and homocysteine (Hcy) but negatively correlated
with antioxidants (CAT and GST). In 2348 participants living in
London, the strength of association between intima-media thickness, a
measure of subclinical atherosclerosis, and PM10 mass concentration
was stronger than that for the OP of PM10, possibly however owing to
OP assay underestimating the total oxidative burden of PM [62]. In 22
randomly selected participants in the Normative Aging Study cohort, a
signiﬁcant association was found between long-term ambient PM2.5
exposures and levels of multiple extracellular vesicle-encapsulated mi-
croRNAs (evmiRNAs) circulating in serum [63]. Extracellular vesicles
are double-lipid membrane vesicles that play an important role in the
cell-to-cell communication process by transporting biologically active
molecules such as non-coding micro RNA (miRNA) molecules that re-
press target gene expression by translational inhibition or mRNA de-
gradation. In silico pathway analysis on PM2.5-associated evmiRNAs
identiﬁed several key related pathways, including OS, inﬂammation
and atherosclerosis.
3.2. Animal studies
The use of transgenic mouse models (deﬁcient in ApoE [ApoE-/-] or
LDL [LDL-/-] receptors) in demonstrating the role of a localized oxi-
dative insult in the development and/or enhancement of atherosclerosis
following PM exposure is well established [64,65]. More recently,
evidence stemming from earlier studies has been strengthened by re-
search investigating the molecular pathways through which OS oper-
ates following experimental exposure to diﬀerent types of PM. For DE,
Bai et al [66] showed that exposure (200 μg/m3; 6 h/day, 5 days/week
for 7 weeks) to ApoE-/- mice augmented plaque lipid content, cellu-
larity, foam cell formation and smooth muscle as well as increasing
expression of plaque OS markers, iNOS, CD36, and 3-nitrotyrosine (3-
NT; the well documented biomarker of peroxynitrite [23]), and en-
hancing systemic lipid and DNA oxidation detected by urinary 15-F2t-
isoprostane (15-F2t-IsoP) and 8-oxodGuo respectively. Miller et al [67]
employed a DEP instillation study at a dose (35 μg twice a week for 4
weeks) representing the upper range a person may be exposed to in a
heavily polluted city over 24 h. This regimen increased plaque size,
number, lipid rich area and frequency of buried ﬁbrous caps in ApoE-/-
mice, which despite the lack of systemic inﬂammation, correlated with
lung inﬂammation and antioxidant gene expression in livers (HO-1,
NADPH-quinone oxidoreductase 1 and NF-E2-related factor-2), in-
dicative of a counter-regulatory response to systemic pro-oxidative ef-
fects. Lipid peroxidation in plasma and liver following inhalational
exposure of ApoE/- mice to DE (250 μg/m3, 2 weeks) was associated
with impaired HDL anti-oxidant capacity [68]. UFP exposure has also
been shown to trigger reduced HDL antioxidant capacity, pro-athero-
genic lipid metabolism and a greater atherosclerotic lesion in LDLR-/-
mice, whilst D-4F (an apolipoprotein A-1 mimetic peptide) attenuated
these eﬀects, suggesting a role for lipid oxidation in UFP-mediated
atherosclerosis [69]. Inhalational exposure of ApoE/- mice to environ-
mental air pollutants from vehicular sources (250 μg/m3 diesel PM and
50 μg PM/m3 gasoline exhausts; 6 h/d for 7 days) resulted in LOX-1-
mediated vascular OS (TBARS; DHT staining), expression of MMP-9 and
ET-1 and monocyte/macrophage inﬁltration, all of which, as discussed
above, are associated with progression of atherosclerosis and athero-
sclerotic plaque rupture [32]. In a Manhattan CAP exposure (6 h/day, 5
days/week, 4 months) study using ApoE-/- mice, Ying et al [70] de-
monstrated that ambient PM enhances atherosclerosis through the
NADPH oxidase–dependent induction of O2*- and reactive nitrogen
species in the aorta, causing decreased guanine cyclase–dependent ar-
terial constriction in response to phenylephrine.
3.3. In vitro studies
The pro-oxidative eﬀects of PM has been observed in a number of
cell types that are key players in the development of atherosclerotic
lesions including endothelial cells [46,48,71], macrophages/monocytes
[46] and possibly smooth muscle cells [72]. Increased OS (DCFH-DA
oxidation) may not however completely explain particle-induced lipid
accumulation [46,73]. Whilst exposure of THP-1 derived human mac-
rophages to CB nanoparticles (25 μg/ml 24 h) increased cellular lipid
load suggesting that the monocytes were transforming into foam cells,
this occurred at concentrations lower than those required to trigger
increased intracellular oxidant production [46]. Furthermore, whilst
the presence of the antioxidant buthionine sulphoximine (BSO) in-
creased the CB-induced DCFH-DA oxidation, it showed no eﬀect on
particle-induced lipid accumulation. Automobile DEP (10 μg/ml, 24 h)
has also been demonstrated to induce lipid droplet formation in mac-
rophages but again, at concentrations that were not associated with
increased generation of oxidants [73].
4. Pro-coagulant changes
If an atherosclerotic plaque becomes physically disrupted, the pro-
coagulant material within its core is exposed to coagulation proteins in
the circulating blood and this triggers thrombosis (blood clot forma-
tion) that can block an artery. Thrombus formation thus underlies the
acute complications of atherosclerosis, increasing the risk of potentially
fatal events such as myocardial infarction, stroke or limb ischemia.
Studies evaluating the involvement of OS in eﬀects that air pollution
exposure on triggering thrombotic cardiovascular events are discussed
below (Table 3).
4.1. Human studies
In a panel of 60 elderly subjects with coronary artery disease,
traﬃc-related air pollutants were associated with increased systemic
inﬂammation, soluble platelet selectin (sP-selectin; a biomarker of
thrombosis) and decreased erythrocyte antioxidant enzyme activity
(GPx1 and Cu,ZnSOD) [74]. Within subject inverse associations of sP-
selectin with Cu,ZnSOD were observed in mixed models. Changes in
gene expression connected with key OS and coagulation pathways have
also been identiﬁed in a group of 14 young healthy subjects exposed to
DE (300 μg/m3, 60 min on 2 separate days) in a controlled setting [75].
A decrease in proteins involved in the ﬁbrinolytic pathway (plasmi-
nogen and thrombomodulin) was detected following a 2-h controlled
exposure of 34 subjects with metabolic syndrome (MeS) to concentrated
ambient ultraﬁne particles (UCAPs), however GSTM1-individuals were
not more responsive than the entire study population [76]. Furthermore
on investigating coagulation pathways in a panel of 31 healthy, young
volunteers semi-experimentally exposed for 5 h to ambient air pollution
at 5 locations with contrasting air pollution characteristics, PM10 OP
did not display a strong or consistent association with the examined
endpoints [77]. As discussed by the authors, this could potentially re-
ﬂect the fact that the OP assay employed only examined a fraction of
PM in vivo biological activity.
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4.2. Animal studies
Gaseous and particulate air pollution exposures in animals have
been shown to be associated with both OS and disturbed coagulatory
hemostasis. These include an eﬀect of an ultraﬁne carbon particle
(180 μg/m3, 24 h) inhalation on pulmonary and systemic inﬂammation
in aged SH rats that was associated with increased pulmonary expres-
sion of HO-1 as well as systemic changes in biomarkers of thrombosis
(ﬁbrinogen, TF) [78]. In rats exposed to O3 (0.4 ppm) or DEP (2.1 mg/
m3) for 16 weeks, biomarkers of OS (HO-1) and thrombosis (tissue
factor [TF], plasminogen activator inhibitor-1 [PAI-1], tissue plasmi-
nogen activator [tPA], and von Willebrand factor [vWF]) were in-
creased in the aorta, but not in the heart, possibly triggered by oxida-
tively modiﬁed lipids and proteins through LOX-1 and/or RAGE
signaling [36]. Pre-treatment of mice with the cysteine (the amino acid
that is limiting for GSH synthesis) prodrug l-2-oxothiazolidine-4-car-
boxylic acid, before IT instillation of DEP (30 μg), suggests that OS is at
least partly responsible for the pulmonary and systemic inﬂammation
and thrombotic events in the pial cerebral microvessels (intracranial
vessels on the surface of the brain within the pia–arachnoid) [79]. Si-
milarily, emodin (1,3,8-trihydroxy-6-methylanthraquinone; an antra-
quinone that is extracted from the root of the rhubarb plant), which has
strong antioxidant and anti-inﬂammatory eﬀects, ameliorated the fol-
lowing eﬀects of DEP (1 mg/kg): increased heart tissue levels of IL-1β
and TNF, decreased SOD and glutathione reductase activities and the
prothrombotic eﬀect of DEP in pial arterioles and venules [80]. Fur-
thermore, emodin prevented platelet aggregation in vitro in whole
blood, and the shortening of activated partial thromboplastin time and
prothrombin time caused by DEP.
4.3. In vitro studies
A causal link between the oxidative eﬀects of PM exposure and
procoagulant responses has also been suggested in human endothelial
cells following exposure to soluble UFPs [81]. The exposure induced
thrombin generation and ﬁbrin clot formation via TF upregulation,
Table 2
Studies linking air pollution exposure to atherosclerosis mediated by oxidative stress.
Human studies
Study (reference) Population/design Air pollutant Main ﬁndings




PM2.5 Fe and Ni and PM2.5 from traﬃc emissions and coal combustions
positively associated with ox-LDL; calcium associated with an increase in
soluble CD36
Brucker et al. [61] 39 taxi drivers and 21 non-
occupationally exposed persons
Traﬃc related Increased urinary 1-OHP levels positively correlated with ox-LDL and Hcy but
negatively correlated with CAT and GST
Tonne et al. [62] 2348 participants of the
Whitehall II cohort




22 participants of NAS cohort Ambient PM2.5 Signiﬁcant association between long-term ambient PM2.5 exposures and levels
of evmiRNAs circulating in serum several of which were enriched in OS
inﬂammation and atherosclerosis pathways
Animal studies
Study (reference) Animal model Air pollutant exposure Main ﬁndings (exposed versus control)
Bai et al. [66] ApoE-/- mice DE (200 μg/m3); 6 h/d, 5 d/wk for
7 wk
Augmented plaque lipid content, cellularity, foam cell formation and smooth
muscle; increased expression of plaque iNOS, CD36, and 3-NT, and enhanced
systemic lipid and DNA oxidation (15-F2t-IsoP and 8-oxodGuo)
Miller et al. [67] ApoE-/- mice DEP (35 μg) 2 x/wk for 4 wk Increased plaque size, number, lipid rich area and frequency of buried ﬁbrous
caps; correlated with liver HO−1, NADPH-quinone oxidoreductase 1 and NF-
E2-related factor−2 gene expression
Yin et al. [68] ApoE-/- mice DE (250 μg/m3) 2 wk Lipid peroxidation in plasma (8-isoprostanes, 12-hydroxyeicosatetraenoic acid,
13-hydroxyoctadecadienoic acid) and liver (MDA) associated with impaired
HDL anti-oxidant capacity
Li et al. [69] LDLR-/- mice UFP (360 μg/m3) 5 h/d, 3 d/wk,
for 10 wks
Reduced HDL anti-oxidant capacity, pro-atherogenic lipid metabolism, greater
atherosclerotic lesion; eﬀects attenuated by D-4F
Lund et al. [32] ApoE/- mice DEP (250 μg/m3) and gasoline
exhaust particles (50 μg/m3) 6 h/d
for 7d
LOX−1-mediated vascular OS (TBARS; DHT staining), expression of MMP−9
and ET−1 and monocyte/macrophage inﬁltration
Ying et al. [70] ApoE-/- mice PM2.5 CAP exposure (138 μg/m3)
6 h/d, 5 d/wk, for 4 mo
Increased aortic expression of p47phox, rac1 and iNOS, increased O2*- and
protein nitration in the aorta, increased plaque area of thoracic aorta,
macrophage inﬁltration and lipid deposition
In vitro studies
Study (reference) Cells/tissue Air pollutant exposure Main ﬁndings (exposed versus control)
Cao et al. [46] THP−1 derived human
macrophages
CB (25 μg/ml) Increased cellular lipid load at concentrations lower than those required to
trigger intracellular DCFH-DA oxidation; BSO increased CB-induced oxidants
but showed no eﬀect on particle-induced lipid accumulation.
Cao et al. [73] THP−1 derived human
macrophages
DEP (10 μg/ml) Induce lipid droplet formation at concentrations not associated with increased
DCFH-DA oxidation
1-OHP: 1-hydroxypyrene; 3-NT: 3-nitrotyrosine; 8-oxodGuo: 8-oxo-7,8-dihydro-2’-deoxyguanosine; 15-F2t-IsoP: 15-F2t-isoprostane; BSO: buthionine sulphoximine; CAP: concentrated
ambient particle; CAT: catalase; CB: carbon black; CD36: oxoLDL receptor; CIMT: carotid intima-media thickness; DCFH-DA: dichlorodihydroﬂuorescein diacetate; DE: diesel exhaust;
DEP: diesel exhaust particle; DHT: dihydroethidium; ET-1: endothelin-1; Fe: iron; GST: glutathione transferase; Hcy: homocysteine; HDL: high density lipoprotein; HO-1: hemeoxygenase-
1; iNOS: inducible nitric oxide synthase; LOX-1: lectin-like oxidized low-density lipoprotein; MDA: malondialdehyde; MMP: matrix metalloprotease; NADPH: nicotinamide adenine
dinucleotide phosphate, reduced; Ni: nickel; NAS: Normative Ageing Study; OP: oxidative potential; OS: oxidative stress; O2*-: superoxide anion radical; oxLDL: oxidized low-density
lipoprotein; PM2.5: particulate matter less than 2.5 µm in diameter; PM10: particulate matter less than 10 µm in diameter; UFP: ultraﬁne particle.
F.J. Kelly, J.C. Fussell Free Radical Biology and Medicine 110 (2017) 345–367
351
involving intracellular hydrogen peroxide (H2O2) production and the
NOX-4 isoform of NADPH oxidase. Exemplifying the likely overlapping
eﬀects of cellular oxidative imbalances on cardiovascular events, mi-
tochondrial OS is believed to play a role in a recently uncovered me-
chanism by which activation of the sympathetic nervous system fol-
lowing particulate air pollution exposure increases the risk of
thrombotic cardiovascular events [82]. In an elegant and extensive
series of animal and in vitro experiments utilizing non-selective and
mitochonrial antioxidants as well as electron transport chain inhibitors,
Chiarella et al [82] describes a systemic increase of catecholamine in-
duced by CAPs (PM2.5) that augments the release of IL-6 from lung
macrophages via a pathway that requires mitochondrial oxidants and
adenylyl cyclase, and cAMP response element-binding protein, which in
turn contributes to a hypercoagulable state (Fig. 2).
5. Autonomic nervous system dysfunction
One way in which the body responds to environmental stressors is
by triggering autonomic reﬂexes in pulmonary receptors, baroreceptors
and chemoreceptors. Indeed, modulation of autonomic neural input to
the heart and vasculature following direct activation of sensory nerves
in the respiratory system, is thought to be a key mechanistic pathway
by which exposure to air pollution aﬀects cardiovascular health in-
dicators - especially acute outcomes [8]. Moreover, there is evidence
that these eﬀects may be mediated through OS related mechanisms
(Table 4). Much of the evidence linking changes in cardiac autonomic
tone with exposure to air pollution comes from studies of heart rate
variability (HRV). Heart rate variability is the measurement of variation
in the time interval between heartbeats, and is a quantitative and non-
invasive indicator of the balance between the sympathetic and para-
sympathetic branches of the ANS and hence cardiovascular disease.
High HRV is traditionally considered positive because the heart has the
ability to respond to rapidly changing environments. Low HRV, re-
ﬂecting increased sympathetic tone, is associated with a heightened risk
of cardiac arrhythmia and mortality in people with heart disease.
Table 3
Studies linking air pollution exposure to pro-coagulant changes mediated by oxidative stress.
Human
Study [reference] Population/design Air pollutant Main ﬁndings
Delﬁno et al. [74] Panel study of 60 elderly subjects
with coronary artery disease
Traﬃc-related air pollutants Association with increased systemic inﬂammation and sP-selectin and
decreased erythrocyte GPx1 and Cu,ZnSOD activity
Pettit et al. [75] Controlled exposure; 14 young
healthy subjects
DE (300 μg/m3) 60 min on 2 separate
days
Changes in gene expression connected with key OS and coagulation
pathways
Devlin et al. [76] Controlled exposure; 34
individuals with MeS
UCAP (98 μg/m3) 2 h Changes in plasminogen and thrombomodulin in GSTM1 null individuals
not more responsive than the entire study population
Strak et al. [77] Semi-experimental exposure; 31
healthy young volunteers
Ambient air pollution at 5 locations with
contrasting air pollution characteristics
for 5 h
No strong or consistent association between coagulation and PM10 OP
Animal
Study [reference] Animal model Air pollutant exposure Main ﬁndings (exposed versus control)
Upadhyay et al. [78] Aged SH rats Ultraﬁne carbon particle (180 μg/m3)
24 h
Pulmonary and systemic inﬂammation associated with increased
pulmonary expression of HO−1 and systemic changes in ﬁbrinogen and
TF
Kodavanti et al. [36] Wistar rats O3 (0.4 ppm) or DEP (2.1 mg/m3) for 16
weeks
Increased aortic HO−1, PAI−1, tPA and vWF, possibly triggered by
oxidatively modiﬁed lipids and proteins through LOX−1 and/or RAGE
signaling
Nemmar et al. [79] Tuck Ordinary mice pre-treated
with cysteine prodrug OTC
DEP (IT, (15 or 30 μg) Macrophage and neutrophil inﬂux in BALF, elevated TEAC, decreased
plasma TEAC, shortened bleeding time, platelet proaggregatory eﬀect in
pial cerebral venules; eﬀects reversed by OTC
Nemmar et al. [80] Tuck Ordinary mice pre-treated
with emodin
DEP (IT, 1 mg/kg) Cardiac tissue: increased IL−1β and TNF, decreased SOD and glutathione
reductase activities; pial arterioles and venules: prothrombotic eﬀect;
whole blood: platelet aggregation and shortening of activated partial
thromboplastin time and prothrombin time. All eﬀects prevented by
emodin
In vitro
Study [reference] Cells/tissue Air pollutant exposure Main ﬁndings (exposed versus control)
Snow et al. [81] HAEC Soluble UFP (10, 50 and 100 μg/ml) Earlier thrombin generation and ﬁbrin clot formation abolished by an
anti-TF antibody, increased intracellular H2O2 production involving
NOX−4 enzyme, antioxidants attenuated UFP-induced upregulation of
TF
Chiarella et al. [82] Murine alveolar macrophages CAP (10 μg/m2) PM induced mitochondrial oxidant generation primes adenylyl cyclase,
enhancing β2AR-mediated generation of cAMP and phosphorylation
CREB to augment IL6 transcription
NB in mice, β2AR signaling promotes prothrombotic state suﬃcient to
accelerate arterial thrombosis
β2-AR: β2-adrenergic receptor; BALF: bronchoalveolar lavage ﬂuid; cAMP: Cyclic adenosine monophosphate DE: diesel exhaust; CREB: cAMP response element-binding protein; GPx:
glutathione peroxidase; GSTM1: glutathione S-transferase-M1; H2O2: hydrogen peroxide; HAEC: human aortic endothelial cell; HO-1: hemeoxygenase-1; IL-1β: interleukin-1β; IT:
intratracheal; LOX-1: lectin-like oxidized low-density lipoprotein; MeS: metabolic syndrome; O3:ozone; OP: oxidative potential; OS: oxidative stress; OTC: l-2-oxothiazolidine-4-carboxylic
acid; PAI-1: plasminogen activator inhibitor-1; RAGE: receptor for advanced glycation end products; SH: spontaneously hypertensive; SOD: superoxide dismutase; TEAC: Trolox
equivalent antioxidant capacity; TF: tissue factor; TNF: tumor necrosis factor; tPA: tissue plasminogen activator; UCAP: concentrated ambient ultraﬁne particle; vWF: von Willebrand
factor.
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5.1. Human studies
In the initial epidemiological studies using elderly male participants
of the Normative Aging Study, functional genetic variations in GSTM1,
HMOX-1 and HFE, all of which are involved in defense against OS,
modiﬁed susceptibility to PM2.5 induced changes in HRV [83–85]. More
recently, Baja et al [86] reported a stronger association between the
heart-rate–corrected QT interval (QTc; a marker of ventricular re-
polarization and risk factor for ventricular arrhythmias and sudden
cardiac death) and elevated short-term exposure to BC among 580
Normative Aging Study participants who had a high number of un-
favorable genotypes related to OS, as well those who were obese or
diabetic. Another study conducted among a panel of elderly Asian re-
sidents using genetic risk scores again suggests that the association of
Fig. 2. PM-induced oxidant generation and priming of adenylyl cyclase are required for β2 agonist–mediated worsening of IL-6 release. (A) MH-S cells and (B) primary alveolar
macrophages (AM) were treated with PM (10 μg/cm2) or control (medium) and IL-6 levels were measured in the absence or presence of a mitochondrially targeted antioxidant (Mito-Q or
control [TPP]) or (C) a nontargeted antioxidant (EUK-134) (20 μM). (D) MH-S cells were treated with PM or control and with forskolin (50 μM) or control and cAMP levels were measured
1 min after forskolin treatment. (E) MH-S cells were treated with antimycin A (AA) (1 μM) or vehicle and with forskolin (50 μM) and IL-6 was measured in the medium 24 h later in the
absence or presence of stigmatellin (1 μM). (F) MH-S cells were treated with PM or control and with forskolin (50 μM) or control and IL-6 levels were measured 24 h later in the absence or
presence of stigmatellin. (G) MH-S cells were treated with PM or control and with EUK-134 or control and immunoblotting was performed against cAMP CREB in the nuclear and
cytoplasmic fractions 4 h later. (H) IL-6 levels were measured in control and CREB shRNA–transfected MH-S cells after treatment with PM or PBS. (I) Control and p65-shRNA–transfected
cells were treated with PM or control and with albuterol or control and IL-6 levels were measured. *P< 0.05, PM vs. PBS; **P< 0.05, albuterol or forskolin vs. control; ‡P<0.05,
Adrb1+/+Adrb2–/– vs. Adrb1+/+Adrb2+/+, AC inhibitor, mito-Q, EUK-134, or stigmatellin vs. control, CREB or p65 vs. control shRNA. Reprinted with permission from Chiarella et al.
[82].
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air pollution with HRV, as well BP, are mediated by OS pathways [87].
In a post-infarction population, total antioxidant capacity (TAC) how-
ever did not appear to modify the association between short-term am-
bient PM2.5 concentrations and biomarkers of HRV and repolarization
[88]. That oxidative pathways exacerbate the adverse eﬀects of am-
bient levels of air pollution on the cardiac autonomic function has also
been investigated by looking at associations between air pollution ex-
posure, biomarkers of OS and HRV [89–93]. Whilst Lee et al [91] re-
ported that OS modiﬁed the association between continuous personal
exposure to PM2.5 and HRV, the markedly improved air quality brought
about by the 2008 Olympic Games in Beijing was not mirrored by a
change in HRV measurements despite decreases observed in urinary 8-
oxodGuo [90]. Exhaled MDA levels were slightly, but insigniﬁcantly,
elevated in a group of asthmatic and non-asthmatic subjects who ex-
perienced decreases in HRV following a 2-h highway commute during
rush hour [92]. Another study observed that a 5-h exposure to real-life
levels of PM2.5 from an urban street (24 μg/m3) reduced HRV as well as
causing vasomotor dysfunction in overweight middle-aged and elderly
adults. However these eﬀects were not associated with the altered
biomarkers chosen to measure OS (dihydrobiopterin, biopterin, uric
acid, ascorbic acid and dehydroascorbate) [93]. The mitochondrion is
the primary target of OS in response to exogenous environments,
leading to mitochondrial DNA (mtDNA) damage through methylation
of nucleotides. An occupational exposure study thus speciﬁcally ex-
amined the association between metal-rich PM2.5 from welding and
blood mtDNA methylation in relation to HRV [94]. Blood mtDNA me-
thylation levels were signiﬁcantly lower in participants who were
highly exposed to PM, whilst workers with higher levels of mtDNA
methylation were more susceptible to the eﬀect of PM2.5 exposure on
HRV measures. Studies examining the impact of antioxidant supple-
mentation on the cardiovascular eﬀects of pollution exposure include
that of Romieu et al [95] who reported omega-3 polyunsaturated fatty
acid supplementation attenuated the eﬀect of same-day indoor PM2.5 on
HRV among elderly residents of a nursing home in Mexico City. More
recently, in a controlled human exposure study (CAP mean mass con-
centration 278± 19 μg/m3 for 2 h) omega-3 fatty acid supplementa-
tion (3 g/day for 4 weeks), attenuated the CAP-induced changes in HRV
and cardiac repolarization in healthy, middle-aged healthy adults [96]
(Fig. 3).
Table 4
Studies linking air pollution exposure to autonomic nervous system dysfunction mediated by oxidative stress.
Human
Study [reference] Population/design Air pollutant Main ﬁndings
Baja et al. [86] 580 NAS participants of NAS cohort Traﬃc-related pollution Stronger association between QT and elevated short-term
exposure to BC among subjects with high number of
unfavorable genotypes related to OS, as well as in non-
smokers, obese individuals or diabetics
Kim et al. [87] Panel of 547 elderly Asian residents Ambient PM10, SO2, NO2 Genetic risk scores suggests association of air pollution with
HRV are mediated by OS pathways
Wang et al. [88] 76 patients with a recent coronary event Ambient PM2.5 TAC does not appear to modify the association between
short-term ambient PM2.5 concentrations and HRV/
repolarization biomarkers
Zhang et al. [90] 125 healthy young subjects Ambient air pollutants pre, during and post
Beijing Olympics
Improved air quality brought about by the 2008 Olympic
Games in Beijing was not mirrored by a change in HRV
measurements despite decreases observed in urinary 8-
oxodGuo
Lee et al. [91] 44 adults Personal PM2.5 OS modiﬁed the association between personal PM2.5
exposure and HRV
Sarnat et al. [92] 21 asthmatic and 21 non-asthmatic
subjects
2-h highway commute during rush hour Slight and insigniﬁcant elevation of exhaled MDA levels in
subjects who experienced decreases in HRV following
Hemmingson et al.
[93]
Controlled exposure; 60 overweight
middle-aged, elderly adults
real-life levels of PM2.5 from an urban street
(24 μg/m3) for 5 h
Reduced HRV and vasomotor dysfunction; eﬀects not
associated with OS biomarkers (dihydrobiopterin,
biopterin, uric acid, ascorbic acid, dehydroascorbate)
Tong et al. [96] Controlled exposure; 29 healthy middle-
aged adults supplemented with ﬁsh oil or
olive oil (3 g/day for 4 weeks)
CAP (278±19 μg/m3) for 2 h Fish oil supplementation attenuated CAP-induced changes
in HRV and cardiac repolarization in
Byun et al. [94] Occupational exposure; 48 workers in a
boilermaker unit
Metal-rich PM2.5 from welding Blood mtDNA methylation levels negatively associated
with PM2.5 exposure; greater susceptibility of workers with
higher levels of mtDNA methylation to eﬀect of PM2.5
exposure on HRV measures
Animal
Study [reference] Animal model Air pollutant exposure Major ﬁndings (exposed versus control)
Kim et al. [98] Sprague–Dawley rats DEP (ET, 200 μg/ml) for 30 min and perfused
rat hearts (12.5 μg/ml for 20 min)
Action potential duration prolongation, early
afterdepolarization and ventricular arrhythmia - all
prevented by pretreatment with NAC as well as active
Ca2+/calmodulin-dependent protein kinase II blockade
Robertson et al. [99] Wistar ats DEP (IT, 0.5 mg) Oxidant stress (EPR) of heart perfusate before IR, increased
vulnerability to ischemia-associated arrhythmia
Wang et al. [100] Wistar rats PM2.5 (0.2, 0.8, 3.2 mg)
and/or O3 (0.81 ppm)
O3 potentiated PM2.5-induced increase in heart MDA and
decreased HRV
Andre et al. [101] Wistar rats CO (30 ppm) 12 h, including ﬁve 1 h peaks at
100 ppm for 4 wks
Increased ventricular MDA, altered Ca2+ homeostasis and
ventricular arrhythmia
8-oxodGuo: 8-oxo-7,8-dihydro-2’-deoxyguanosine; BC: black carbon; CAP: concentrated ambient particle; CO: carbon monoxide; DEP: diesel exhaust particle; EPR: electron paramagnetic
resonance; HRV: heart rate variability; IR: insulin resistance; MDA: malondialdehyde; NAC: N-acetylcysteine; NAS: Normative Ageing Study; NO2: nitrogen dioxide; O3:ozone; OS:
oxidative stress; PM2.5: particulate matter less than 2.5 µm in diameter; PM10: particulate matter less than 10 µm in diameter; SO2: sulphur dioxide; TAC: total antioxidant capacity.
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5.2. Animal studies
Findings from animal studies investigating the arrhythmogenic
mechanism of particulate pollution are also consistent with OS medi-
ated pathways of injury [97–99]. Following endotracheal DEP exposure
to rats (200 μg/ml for 30 min) and perfused rat hearts (12.5 μg/ml for
20 min), Kim et al [98] observed action potential duration prolonga-
tion, early after depolarization and ventricular arrhythmia that were
prevented by pretreatment with NAC as well as active Ca2+/calmo-
dulin-dependent protein kinase II blockade. Oxidant stress, determined
by electron paramagnetic resonance of heart perfusate before induction
of ischemia and reperfusion, in the absence of recruited inﬂammatory
cells, along with increased vulnerability to ischemia-associated ar-
rhythmia has also been observed in rats following a large IT DEP in-
stallation (0.5 mg) [99]. Whilst Wang et al [100] reported that O3 alone
(0.81 ppm) exposures did not signiﬁcantly alter indicators (increased
heart MDA, decreased HRV) adversely aﬀected by PM2.5 (0.2, 0.8,
3.2 mg/rat), the gaseous pollutant potentiated the eﬀects induced by
PM2.5. The only other gaseous pollutant that has been investigated in
this regard is CO in a chronic exposure (30 ppm for 12 h, including ﬁve
1 h peaks at 100 ppm for 4 weeks) to rats, which promoted OS (ven-
tricular MDA), altered Ca2+ homeostasis and ventricular arrhythmia
[101].
6. Hypertension
It is believed that elevations in BP brought about by constituents of
ambient air pollution occur in a biphasic fashion [12]. Owing to the
rapidity of observed eﬀects and associations with parameters of HRV,
the activation of pulmonary reﬂexes and subsequent imbalanced acti-
vation of the ANS has been postulated to play a role in the initial re-
sponse (minutes to hours). Controlled exposure studies in animals
suggest the later-onset eﬀects following longer-term exposures however
maybe explained by heightened arterial vasoconstrictor responsiveness
mediated via a variety of mechanisms including OS and inﬂammation,
activation of vasoactive mediators [72] and vascular remodeling
[72,78,99,102]. Studies that allow an evaluation of a role of OS in the
pro-hypertensive eﬀects of air pollution are discussed below (Table 5).
6.1. Human studies
Relatively few studies have investigated interactions between ge-
netic polymorphisms and air pollution exposure for hypertension and
moreover, results have been inconsistent. Among 461 elderly men in
the Normative Aging Study, traﬃc-related BC particles were associated
with increased in systolic (SBP) and diastolic (DBP) blood pressure, an
eﬀect that was not however modiﬁed by gene variants related to OS
defense (GSTM1, GSTP1, GSTT1, GSTCD, NQO1, CAT, HMOX-1) [103].
Similarly, in a larger Swedish study (n=1429), associations between
long-term exposure to vehicle NO2 and hypertension were not stronger
among individuals with potentially impaired antioxidant defenses
(gene variants in GSTP1, GSTT1, GSTCD) [104]. In a panel study of
post-infarction patients (n=76), no evidence of eﬀect modiﬁcation by
TAC was found on the associations between ambient PM2.5, accumu-
lation mode particle and UFP concentrations in the previous 6–120 h
and SBP [88]. A more recent study conducted among elderly Asian
participants and employing genetic risk scores did however suggest that
associations of air pollution with BP were mediated, at least partly by
OS pathways [87]. Again using the Normative Aging Study, Zhong et al.
[105] evaluated the role of mitochondrial abundance, an adaptive
mechanism to compensate for cellular-redox-imbalance following en-
vironmental challenges, in a BC-BP relationship. Exposure to short-to
moderate-term ambient BC concentrations was associated with in-
creased BP and blood mitochondrial abundance (as reﬂected in elevated
mitochondrial DNA to nuclear DNA copy number). Furthermore, in-
dividuals with a higher blood mitochondrial abundance appeared less
susceptible to the impact of ambient BC on BP, prompting speculation
that this may be a compensatory response that attenuates the cardiac
eﬀects of traﬃc-related pollution (Fig. 4). In a panel of 50 healthy
people, short-term PM10 exposure was associated with retinal arteriolar
narrowing and venular widening, both being independent risk factors
for cardiovascular disease. Furthermore, analysis of miRNA expression
hinted to a possible role for OS and inﬂammatory pathways [106].
6.2. Animal studies
Exposure to various types of particulate pollution has been reported
to increase BP in rodents along with increased oxygen free radicals
(EPR) in coronary perfusate (0.5 mg DEP by IT in adult rats) and in
association with an induction of HO-1 within the lung (180 μg/m3
Fig. 3. A Eﬀect of CAP exposure on frequency domain indices of HRV. nLF HRV and HF/LF ratio were analyzed in the ECG recordings of participants at rest before, immediately after
exposure to ﬁltered air and CAP (Post), and again the next morning (Follow-up) as described in “Methods.“ Data shown are average changes per 100-µg/m3 increase in CAP relative to the
ﬁltered air and 95% conﬁdence intervals. Reproduced from Environ Health Perspect (Tong et al., 2012). B Eﬀect of CAP exposure on indices of cardiac repolarization. QTc, QTp, and Tp-
Te were analyzed in ECG recordings of participants at rest before, immediately after exposure to ﬁltered air and CAP (Post), and again the next morning (Follow-up) as described in
“Methods.“ Data shown are average changes per 100-µg/m3 increase in CAP relative to the ﬁltered air and 95% conﬁdence intervals. Reproduced from Tong et al. [96].
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ultraﬁne carbon particle by inhalation in aged SH rats) [78,99]. High
dose IT PM2.5 (3.2 mg per rat) alone or in combination with O3
(0.81 ppm), but not O3 alone, increases SBP and heart MDA [100]. In
healthy and SH rats, a 4-week DE inhalation (0.5 or 2 mg/m3, 4 h/day,
5 days/week for 4 weeks) enhanced cardiac mitochondrial OS (aconi-
tase activity) in both species and produced a hypertensive-like gene
expression pattern in the ventricles of healthy rats, characterized by a
generalized suppression of genes (including those related to mi-
tochondrial function and compensatory response to OS) that are already
suppressed in SH rats at baseline without DE [107]. Of interest, hearts
of already hypertensive rats were spared from DE-induced further im-
pairment in gene expression. Earlier work by Sun et al [72] suggests
that at least some of the pro-hypertensive eﬀects of short-term (10
weeks) PM2.5 exposure (79.1±7.4 μg/m3) in rats can be explained by
O2*-, generated through NADPH oxidase, which activates RhoA/Rho-
kinase (ROCK). Moreover since angiotensin II (ANG II) is a well-known
regulator of NADPH oxidases, a pathway has been hypothesized by
which PM2.5 exerts additive eﬀects on ANG II-mediated BP. On in-
vestigating the eﬀect of diﬀerent size PM fractions on renin-angio-
tensin-aldosterone and kallikrein-kinin elements in rats, Aztatzi-Aguilar
et al [108], observed an increased expression of the ANG II receptor
type 1 in the heart that was accompanied by a decrease in HO-1 to-
gether with the induction of Acta1 and Col3a1 (markers of myocardial
adaptive response to damage) and increased coronary wall thickness
following an UFP subchronic exposure (107 μg/m3, 8 weeks (5 h/day, 4
days/week)).
7. CV risk
In addition to being central to eliciting speciﬁc cardiac responses,
evidence also exists that an OS pathway plays a role in modulating the
risk of succumbing to cardiovascular disease following air pollution
exposure (Table 6).
7.1. Human studies
Hyperhomocysteinemia is an important independent predictor for
several CV diseases including atherosclerosis, thrombosis, myocardial
infarction and stroke. Elevations in plasma Hcy is also associated with
traﬃc-related pollutant exposures, especially PM2.5 and BC and more-
over, gene polymorphisms related to OS modify these eﬀects [109].
Speciﬁcally, individuals carrying the deletion of GSTT1 or those with
polymorphisms in the hemochromatosis genes (HFE C282Y) had higher
plasma Hcy when they exposed to BC whilst HFE C282Y and CAT
(rs2300181) modiﬁed eﬀects of PM2.5. In another study, whilst in-
creased urinary 1-OHP levels in taxi drivers were negatively correlated
with CAT &GST, the occupationally exposed individuals also displayed
increased biomarkers of oxidatively generated damage (MDA and PCO)
and serum Hcy levels [61]. Another prominent predictor of negative
cardiac outcomes (such as heart failure, arrhythmia, stroke and sudden
cardiac death) is an elevated left ventricular mass (LVM). Work within
the MultiEthnic Study of Atherosclerosis initially demonstrated a link
between close (< 50 m) residential major roadway proximity and
Table 5
Studies linking air pollution exposure to hypertension mediated by oxidative stress.
Human
Study [reference] Population/design Air pollutant Main ﬁndings
Mordukhovich et al.
[103]
461 participants of NAS cohort Traﬃc-related BC particles Associations with increased SBP and DBP not modiﬁed by gene variants
related to OS defense (GSTM1, GSTP1, GSTT1, GSTCD, NQO1, CAT,
HMOX−1)
Levinsson et al. [104] 119 AMI cases and 1310
controls
Traﬃc-related NO2 Associations between long-term vehicle NO2 and hypertension not stronger
among individuals with potentially impaired antioxidant defenses (gene
variants in GSTP1, GSTT1, GSTCD)
Wang et al. [88] Panel study of 76 post-
infarction patients
Ambient PM2.5 and UFP No evidence of eﬀect modiﬁcation by TAC on associations between ambient
PM2.5, accumulation mode particle and UFP concentrations and SBP
Kim et al. [87] Panel of 547 elderly Asian
residents
Ambient PM10, SO2, NO2 Genetic risk scores suggest associations of air pollution with BP were
mediated by OS pathways
Zhong et al. [105] 675 participants of NAS cohort Ambient BC Short-to moderate-term ambient BC concentrations associated with
increased BP and blood mitochondrial abundance; individuals with a higher
blood mitochondrial abundance appeared less susceptible to the impact of
ambient BC on BP
Louwies et al. [106] 50 healthy people Ambient PM10 Short-term PM10 exposure associated with retinal arteriolar narrowing and
venular widening; analysis of miRNA expression hinted to a possible role for
OS and inﬂammatory pathways
Animal
Study [reference] Animal model Air pollutant exposure Major ﬁndings (exposed versus control)
Upadhyay et al. [78] Aged SH rats Ultraﬁne carbon particles (180 μg/
m3) for 24 h
Increased BP in association with an induction of pulmonary HO−1
Robertson et al. [99] Wistar rats DEP (IT, 0.5 mg DEP) Increased BP and oxygen free radicals (EPR) in coronary perfusate before
induction of IR
Wang et al [156] Wistar rats PM2.5 (IT, 3.2 mg) alone or in
combination with O3 (0.81 ppm) for
4 h
PM2.5 alone or in combination with O3 (but not O3 alone), increased SBP and
heart MDA
Gottipolu et al. [107] SH rats DE (0.5 or 2 mg/m3) 4 h/d, 5 d/wk
for 4 wks
Hypertensive-like cardiac gene expression pattern associated with
mitochondrial oxidative stress in healthy rats
Aztatzi-Aguilar et al.
[108]
Sprague–Dawley rats UFP (107 μg/m3) 5 h/day, 4 d/wk
for 8 wk
Increased expression of the angiotensin II receptor type 1 in heart
accompanied by decreased HO−1, induction of Acta1 and Col3a1 and
increased coronary wall thickness
AMI: acute myocardial infarction; BC: black carbon; BP: blood pressure; CAT: catalase; DBP: diastolic blood pressure; DE: diesel exhaust; DEP: diesel exhaust particle; EPR: electron
paramagnetic resonance; GST: glutathione S-transferase; HO-1: hemeoxygenase-1; IT: intratracheal; MDA: malondialdehyde; NAS: Normative Ageing Study; NO2: nitrogen dioxide;
O3:ozone; OS: oxidative stress; PM2.5: particulate matter less than 2.5 µm in diameter; PM10: particulate matter less than 10 µm in diameter; SBP: systolic blood pressure; SH: sponta-
neously hypertensive; SO2: sulphur dioxide; TAC: total antioxidant capacity; UFP: ultraﬁne particle.
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Fig. 4. Association of ambient black carbon (BC) levels with systolic blood pressure (SBP) at diﬀerent blood mitochondrial DNA to nuclear DNA copy number ratio (mtDNA/nDNA) levels,
Normative Aging Study, 1999–2012. Results were adjusted for: apparent temperature and absolute humidity at the matching time window; race; percentage of major cell types
(lymphocytes, neutrophils, and platelets); age; weekday; date of visit; body mass index; C- reactive protein> 10 mg/L; smoking; alcohol use; season; physical activity; education level;
use of calcium channel blockers, -blockers, and angiotensin-converting enzyme inhibitor. CI: conﬁdence interval. Reprinted with permission from Zhong et al. [105]. Promotional and
commercial use of the material in print, digital or mobile device format is prohibited without the permission from the publisher Wolters Kluwer Health. Please contact healthpermis-
sions@wolterskluwer.com for further information.
Table 6
Studies linking air pollution exposure to cardiovascular risk mediated by oxidative stress.
Human
Study [reference] Population/design Air pollutant Main ﬁndings
Ren et al. [109] 1000 participants of NAS Traﬃc-related Individuals carrying the deletion of GSTT1 or those with polymorphisms in the
hemochromatosis genes (HFE C282Y) had higher plasma Hcy when they
exposed to BC whilst HFE C282Y and CAT (rs2300181) modiﬁed eﬀects of
PM2.5.
Brucker et al. [61] 39 taxi drivers and 21 non-
occupationally exposed persons
Traﬃc-related Increased urinary 1-OHP levels negatively correlated with CAT &GST,
increased biomarkers of oxidatively generated damage (MDA and PCO) and
serum Hcy levels
Van Hee et al. [111] 1376 participants of MultiEthnic
Study of Atherosclerosis
Proximity to major road Link between close (< 50 m) residential major roadway proximity and higher
LVM modiﬁed by polymorphisms in genes important in vascular function and
inﬂammation/OS (AGTR1 and ALOX15)
Levinsson et al. [104] 119 AMI cases and 1310 controls Traﬃc-related NO2 AMI risk modiﬁed (not signiﬁcantly) by genetic variants in the GST genes
Dominguez-Rodriguez
et al. [112]
307 patients admitted to hospital due
to acute coronary syndrome
Ambient BC High BC exposure and OS marker (MDA levels) independently associated with
MACE at 30 days
Weichenthal et al. [113] Case-crossover study including 30101
cases of myocardial infarction
Ambient PM2.5 Regional diﬀerences in glutathione-related OP modiﬁes relationship between
PM2.5 mass concentrations and risk of myocardial infarction; combined oxidant
capacity of NO2 and O3 may further amplify the eﬀect
Animal
Study [reference] Animal model Air pollutant exposure Major ﬁndings (exposed versus control)
Weldy et al. [114] Pregnant female C57Bl/6 J mice In utero DE (~300 μg/m3
PM2.5) 6 h/d, 5 d/wk
Placental injury manifested by OS (3-NT), hemorrhage, focal necrosis, embryo
resorption and inﬂammatory cell inﬁltration; surviving embryos develop
weight gain, altered BP, increased susceptibility to heart failure as adults
1-OHP: 1-hydroxypyrene; 3-NT: 3-nitrotyrosine; AMI: acute myocardial infarction; BC: black carbon; BP: blood pressure; CAT: catalase; DE: diesel exhaust; GST: glutathione S-transferase;
LVM: left ventricular mass; MACE: major adverse cardiovascular event; MDA: malondialdehyde; NAS: Normative Ageing Study; NO2: nitrogen dioxide; O3: ozone; OS: oxidative stress; OP:
oxidative potential; PCO: protein carbonyl; PM2.5: particulate matter less than 2.5 µm in diameter.
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higher LVM and subsequently found that polymorphisms in genes im-
portant in vascular function and inﬂammation/OS (AGTR1 and
ALOX15) were associated with substantial alterations in the associa-
tions [110,111]. Another study reported that in patients admitted to
hospital due to acute coronary syndrome, BC concentration averaged
the 7 days preceding and MDA levels on admission were associated with
a major adverse cardiovascular event (MACE; deﬁned as the combined
result of cardiovascular death, non-fatal myocardial infarction or re-
admission for unstable angina) at 30 days follow-up [112]. Again fo-
cusing on coronary vulnerability, Levinsson et al. [104] reported that
the eﬀect of long-term traﬃc-related air pollution exposure (NO2 an-
nual means) on risk of acute myocardial infarction was modiﬁed by
genetic variants in the GST genes, although the variations were not
statistically signiﬁcant. That regional diﬀerences in the oxidative
properties of PM2.5 may modify its impact on emergency room visits for
myocardial infarction has also been investigated [113]. Findings sug-
gested that not only regional diﬀerences in glutathione-related OP
modify the relationship between PM2.5 mass concentrations and risk of
myocardial infarction, but also that the combined oxidant capacity of
NO2 and O3 may further amplify such an eﬀect.
7.2. Animal studies
Evidence from experimental animal work of a role played by OS in
cardiovascular disease susceptibility mediated by particulate air pol-
lution comes from an in utero DE (300 μg/m3 PM2.5, 6 h/day, 5 days/
week; equating to a 53 μg/m3/h PM2.5 time weighted average) ex-
posure study in mice [114]. This regimen promotes placental injury
manifested by OS (3-NT) as well as hemorrhage, focal necrosis, embryo
resorption and inﬂammatory cell inﬁltration, whilst surviving embryos
develop weight gain, altered blood pressure and increased susceptibility
to heart failure as adults. Of note, the observed increase in placental
vascular OS did not overlap with areas of inﬂammatory cell inﬁltration,
suggesting an alternative source of radical generation.
8. Cardiac dysfunction
Evidence exists that cardiac dysfunction subsequent to air pollutant
exposure is linked with increased OS and/or decrease in antioxidant
reserve (Table 7). Following a chronic O3 exposure (0.8 ppm 8 h/day
for 28 and 56 days) in rats, left ventricular developed pressure (LVDP),
rate of change of pressure development (+dP/ dt) and rate of change of
pressure decay (-dP/dt) values signiﬁcantly decreased and left ven-
tricular end diastolic pressure (LVEDP) was signiﬁcantly increased
[115,116]. The attenuation of cardiac function was associated with
decreased myocardial activities of SOD and increased myocardial lipid
peroxidation. Short-term inhalational exposure to environmentally
persistent free radicals (EPFRs, 20 min/day for 7 days), speciﬁcally 1,2-
dichlorobenzene chemisorbed to 0.2-μm-diameter silica/CuO particles
at 230 °C (DCB230), signiﬁcantly reduce baseline cardiac function in
otherwise healthy rats as a consequence of EPFR-mediated increases in
pulmonary arterial pressure [117]. Moreover, levels of HO-1 and
manganese-dependent SOD in the left ventricle were signiﬁcantly in-
creased. Chronic O3 exposure (0.8 ppm, 8 h/day for 28 and 56 days) of
rats also enhances the sensitivity to ischemia/reperfusion (I/R) injury in
isolated perfused hearts, and again evidence points to a role for OS
[118]. Cardiac function (LVDP, +dP/dt, -dP/dt, and LVEDP) after I/R
was signiﬁcantly compromised and this was associated with increased
myocardial lipid peroxidation and decreased myocardial activities of
SOD. Other work has shown that regular exposure to a simulated urban
CO pollution (air enriched with 30–100 ppm CO, 4 weeks) of rats
worsens myocardial I/R injuries, resulting in increased severity of post
ischemic ventricular arrthymia, impaired recovery of myocardial
function, increased infarct size and a reduced myocardial enzymatic
antioxidant status (SOD, GPx) [119]. More recent work, using a speciﬁc
blocker to inhibit iNOS, suggests that up-regulation of this enzyme
mediates the higher sensitivity of the myocardium to ischemic events
following daily low non-toxic CO exposure, via NO/pro-oxidant de-
pendent pathways, having deleterious eﬀects on diastolic Ca2+ over-
load and myoﬁlaments Ca2+ sensitivity [120] (Fig. 5). In rats, treat-
ment with the antioxidant vanillic acid prior to IT exposure to PM10
(0.5–5.0 mg/kg), improved the observed myocardial dysfunction after
I/R as well as rectifying the observed perturbations in cardiac oxidant
imbalance (xanthine oxidase, lactate dehydrogenase), antioxidant en-
zyme activities (SOD, GPx, CAT) and expression of iNOS and eNOS
mRNA [121].
9. Metabolic disease
Air pollution poses a greater risk of adverse cardiovascular events
for people with metabolic conditions such as insulin resistance (IR),
diabetes mellitus (DM) and obesity. Individuals with DM appear to be
particularly sensitive to the eﬀects that ambient PM exposure has on
heart disease hospital admissions [122–124]. Nanoparticle and CO air
pollution has been reported to elicit ANS dysfunction, manifesting in
signiﬁcant heart rate variations among individuals with MeS but not in
normal subjects [125], whilst obese people may also be at increased risk
[126,127]. Potential mechanisms linking PM to impaired cardiovas-
cular function in such susceptible populations have attracted increased
interest and are undoubtedly the result of a complex interaction of in-
dividual risk factors that are still under investigation. A major under-
lying factor behind increased susceptibility in DM appears to be the
higher propensity for cardiovascular complications within this popu-
lation, for example, preexisting vascular endothelial dysfunction, re-
duced HRV and accelerated atherosclerosis [49,122,123,128–130]. In-
deed studying IR and the development of type 2 DM in relation to air
pollution exposure may well aid in clarifying causative associations
between environmental factors and cardiovascular risk [131,132]. In-
creased OS has emerged as playing a central role in MeS and as such,
may constitute a unifying mechanism underlying the increased pro-
pensity for cardiovascular disease in this complex phenotype. (Table 8).
9.1. Human studies
In evaluating associations between ambient air pollutants and
markers of IR and eﬀect modiﬁcation by genes involved in OS among
560 elderly participants in the Korean Elderly Environmental Panel
study, Kim&Hong [133] reported that PM10, NO2, O3 may increase IR
in the elderly, and that GSTM1-null, GSTT1-null, and GSTP1 AG or GG
genotypes may increase susceptibility. Two-hour controlled exposures
to UFP (50 μg/m3) produced mild changes in gene expression in cir-
culating mononuclear cells of healthy subjects, and pathway analysis
identiﬁed two insulin-related pathways (IGF-1 and insulin receptor
signaling) and pathways related to host defense against environmental
insults (including NRF2-mediated OS signaling) [134].
9.2. Animal studies
Experimental data from studies in rodents investigating mechanisms
linking air pollution and increased risk of cardio-metabolic status have
demonstrated the ability of various PM2.5 exposure regimens to de-
crease insulin sensitivity in various adipose tissues including brown,
white epicardial and perirenal, and induce an inﬂammatory response
plus OS in these tissues [135,136]. The ﬁndings in epicardial adipose
tissue are noteworthy in respect to the possible role of this tissue in
maintaining myocardial form and function. Using wild type versus ge-
netically modiﬁed mice (p47phox homozygous knockout) which are
unable to release O2*- from NADPH oxidase, Xu et al. [137] found that
early life (at 3 weeks of age) exposure to PM2.5 exposure, increases
obesity and systemic IR later in life, likely by NADPH oxidase-derived
oxidants. Recently, a novel link between pulmonary OS and vascular
insulin signaling has been reported, and one that may contribute to the
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mechanism by which air pollution increases the risk for cardiovascular
and metabolic disease. Speciﬁcally, short-term exposure of PM2.5 CAPs
induces IR and inﬂammation in blood vessels of mice, mediated at least
in part by OS in the lungs reﬂected by an increase in the expression
SOD2, SOD3 and GST-α [138]. Pulmonary inﬂammation and increased
tissue and systemic OS (decreased GSH and increased MDA) has also
been postulated to contribute to increased weight gain and metabolic
dysfunction in rat dams and their oﬀspring following pre and postnatal
exposure to unﬁltered Beijing air [139]. Another study has demon-
strated increased cardiovascular vulnerability in a mouse model of type
1 diabetes exposed to IT DEP (0.4 mg/kg) comprising hypoxemia, he-
patotoxicity and acceleration of coagulation comprising thrombosis in
vivo, platelet aggregation in vitro, and the increase in plasma con-
centrations of PAI-1 and vWF [140]. These exacerbations were attrib-
uted to observations of increases in systemic OS (increased plasma 8-
isoprostane) and inﬂammation.
Studies, albeit a limited number, have also investigated whether OS
is involved in O3-induced insulin resistance [136,141,142]. Repeated
O3 inhalation (0.5 ppm, 4 h/day for 13 weeks) induces IR, inﬂamma-
tion and increased expression of OS-related genes (Cox4, Cox5a, Scd1,
Nrf1, Nrf2) in visceral adipose tissue [142]. Another study reported that
overnight exposure of rats to environmentally realistic concentrations
of O3 (0.8 ppm) triggers peripheral IR and systemic OS, in association
with endoplasmic reticulum stress and JNK activation [141]. In that
increases in many OS biomarkers in blood were observed as well as a
decreased GSH-to-GSSG ratio in erythrocytes and an increase in protein
carbonyls in gastrocnemius muscle, suggests OS can spread into per-
ipheral tissues and may mediate remote eﬀects of O3. Muscle cells
treated with bronchoalveolar lavage ﬂuid (BALF) from O3-exposed rats
exhibited an inhibition of insulin-stimulated glucose uptake, whilst
pretreatment of rats with a JNK inhibitor or NAC prior to O3 exposure
alleviated IR. Moreover, BALF from NAC treated O3-exposed animals
failed to impair insulin-signaling pathways in skeletal muscle cells
(Fig. 6). Put together, these ﬁndings suggest that OS, stemming from
toxic lung mediators is instrumental in eliciting the peripheral eﬀects of
O3 on muscle insulin sensitivity.
9.3. In vitro studies
In vitro studies investigating the eﬀects of PM exposure in the
setting of DM or high glucose have focused on macrophages/mono-
cytes, as they are one of the ﬁrst lines of defense against inhaled par-
ticles and respond to PM by secreting various mediators of a vicious
cycle that contribute to cardiovascular disease [143–145]. Mo et al.
[146] demonstrated that in vitro urban PM (SRM 1648, 600 μg/ml)
exposure led to greater DCFH-DA oxidation in alveolar macrophages
from rabbits with DM (as opposed to rabbits without DM) as well as
heightened up-regulation of cytokine expression and pro-MMP-9 ac-
tivity. Findings from the same group reported that co-exposure of
human monocytes to the same urban PM plus high glucose caused a
signiﬁcant increase in DCF ﬂuorescence, phosphorylation of p38, MMP-
2 and MMP-9 mRNA expression and pro-MMP-2/pro-MMP-9 activity
compared with that of urban PM alone [147]. Furthermore, use of NAC
and CAT and a speciﬁc p38 inhibitor suggest that activation of MMPs by
UFP within a high glucose setting is partly mediated via p38 phos-
phorylation induced by OS.
10. Concluding remarks
The large and diverse evidence base, stemming from epidemiolo-
gical research, experimental human and animal studies as well as iso-
lated organ and cellular data indicates that cellular oxidative im-
balances can occur at each of the potential junctures (endothelial
dysfunction, atherosclerosis, pro-coagulant changes, autonomic ner-
vous system dysfunction, hypertension, cardiac dysfunction and in-
creased susceptibility) at which inhaled air pollutants can exert adverse
eﬀects on the cardiovascular system. The studies reviewed have un-
covered numerous mechanistic pathways, acting on several diﬀerent
organ systems, through which pro-oxidative eﬀects may operate
(Fig. 7). Even in the absence of a polluted ambient atmosphere, the
heart is inherently susceptible to oxidative injury [148]. It is an ex-
tremely active organ and as a consequence, has a high metabolic rate to
satisfy the high energy demand. This in turn leads to an increased rate
of production of oxidizing species but at the same time, compared with
other tissues, it is characterized by lower concentrations of SOD, CAT
and GPx [149,150]. It is therefore not surprising that an increased
oxidative burden elicted by air pollution, in addition to being central to
eliciting speciﬁc cardiac endpoints, is also implicated in modulating the
risk of succumbing to cardiovascular disease, sensitivity to I/R injury
and the onset and progression of metabolic conditions and their
Table 7
Studies linking air pollution exposure to cardiac dysfunction mediated by oxidative stress.
Study [reference] Animal model Air pollutant Main ﬁndings (exposed versus control)
Perepu et al. [115] Sprague–Dawley rats O3 exposure (0.8 ppm) 8 h/d for 28
and 56 d
Cardiac dysfunction (decreased LVDP, +dP/ dt and -dP/dt and increased LVEDP)
associated with decreased myocardial activities of SOD and increased myocardial
lipid peroxidation
Sethi et al. [116] Sprague–Dawley rats O3 exposure (0.8 ppm) 8 h/d for 28
and 56 d
Cardiac dysfunction (decreased LVDP) associated with decreased myocardial
activities of SOD
Mahne et al. [117] Sprague–Dawley rats EPFRs (DCB230), 20 min/d for 7 d Reduced baseline cardiac function accompanied by increased HO−1 and
manganese-dependent SOD in the left ventricle
Perepu et al. [118] Sprague–Dawley rats O3 exposure (0.8 ppm) 8 h/d for 28
and 56 d
Enhanced sensitivity to I/R injury in isolated perfused hearts associated with
increased myocardial lipid peroxidation and decreased myocardial SOD
Meyer et al. [119] Wistar rats Simulated urban CO pollution (air
enriched with 30–100 ppm CO) 4 wk
Increased severity of post ischemic ventricular arrthymia, impaired recovery of
myocardial function, increased infarct size and reduced myocardial enzymatic
antioxidant status (SOD, GPx)
Meyer et al. [120] Wistar rats Simulated urban CO pollution (air
enriched with 30–100 ppm CO) 4 wk
Speciﬁc blocker to inhibit iNOS, suggests that up-regulation of iNOS mediates the
higher sensitivity of the myocardium to I/R, via a NO/pro-oxidant dependent
pathway, having deleterious eﬀects on diastolic Ca2+ overload and myoﬁlaments
Ca2+ sensitivity
Dianat et al. [121] Wistar ats pretreated with
vanillic acid
PM10 (IT, 0.5–5.0 mg/kg) Pretreatment with vanillic acid improved observed myocardial dysfunction after
I/R and rectiﬁed perturbations in cardiac oxidative imbalance (xanthine oxidase,
lactate dehydrogenase), antioxidant enzyme activities (SOD, GPx, CAT) and
expression of iNOS and eNOS mRNA
+dP/ dt : rate of change of pressure development; -dP/dt : rate of change of pressure decay; CAT: catalase; CO: carbon monoxide; eNOS : endothelial nitric oxide synthase; GPx:
glutathione peroxidase; HO hemeoxygenase-1; iNOS: inducible nitric oxide synthase; I/R: ischemia/reperfusion; LVDP: left Ventricular Developed Pressure; LVEDP: left ventricular end
diastolic pressure; NO: nitric oxide; O3: ozone; PM10: particulate matter less than 10 µm in diameter; SOD: superoxide dismutase.
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associated complications.
Although both gasses and particles have been linked to detrimental
outcomes, more evidence implicates the PM components for a large
portion of the outcomes investigated. Much of the experimental data
supporting an oxidative pathway originates from studies investigating
the toxic eﬀects of DEPs that contribute signiﬁcantly to the air shed in
many of the world’s largest cities. The toxicological capacity of DEPs is
facilitated by the size (80% of DEPs have an aerodynamic diameter
of< 1 µm) as well as their surface chemistry characteristics. For in-
stance, DEPs have a highly adsorptive carbon core that act as a vector
for the delivery, deep into the lung, of redox active metals, polyaro-
matic hydrocarbons and quinones. Air pollution in urban areas is
however a complex heterogeneous mixture of reactive gases combined
with primary and secondary PM. These particles diﬀer not only in
chemical composition, mass, size, number, shape and surface area, but
also source, solubility and reactivity. Particulate matter can also vary in
space and time as a consequence of atmospheric chemistry and weather
conditions, as well as interactions with O3 and NO2. However, little is
known about OS pathways and cardiac eﬀects caused by individual
pollutants within air pollution mixtures, or as a consequence of inter-
pollutant interactions. In characterizing free radical pathways and the
endothelinergic system in rats after inhalation of urban PM, O3 and a
PM/O3 combination, Kumarathasan et al [151] reported that such
pollutant-speciﬁc changes can be ampliﬁed or abrogated following
multi-pollutant exposures and called upon further studies, adopting a
systems biology approach to validate and give greater insight into these
air pollutant exposure-speciﬁc mechanistic pathways.
The presence of an oxidative imbalance in association with air
pollution induced cardiovascular disease is inferred in many ways in-
cluding increased oxidant production, attenuation or reversal of eﬀect
in the presence of antioxidants or use of transgenic models, markers of
oxidative damage in biological systems, eﬀect modiﬁcation by poly-
morphisms in antioxidant genes and genetic pathway analysis.
Technical diﬃculties associated with analytical approaches, together
with uncertainties in interpretation, mean that despite the considerable
evidence base discussed herein, any limitations must be understood and
when necessary, results should be interpreted with caution [152,153].
Before deﬁnitely attributing a given event to an increased generation of
a speciﬁc reactive oxygen species, accurate detection and character-
ization is paramount. For example, whilst DCFH-DA oxidation to
ﬂuorescent DCF is widely employed for detecting intracellular H2O2,
the complexity of the system’s intracellular redox chemistry means that
there are several limitations and artifacts associated with this technique
for an accurate assessment of intracellular OS. Whilst oxidative damage
biomarkers are routinely employed to indicate production of an oxidant
such as the hydroxyl radical, the link may well be tenuous in that
biomarker accumulation can reﬂect change in clearance rather than in
the production of a given ROS. It is also essential to understand the
Fig. 5. Eﬀect of iNOS inhibition and antioxidant
treatment on the sensitivity to anoxia-reoxygenation
(A/R) of cardiomyocytes from Ctrl and CO rats. A:
representative contraction (left) and intracellular
Ca2+ signal (right) of intact cardiomyocytes fol-
lowing a protocol of A/R. B–E: contraction of intact
myocytes in presence or absence SMT or N-acet-
ylcystein was evaluated by measuring SL shortening
(B), Ca2+ transient amplitude (C), diastolic in-
tracellular Ca2+ (D), and myoﬁlament
Ca2+sensitivity index (E). Data are expressed re-
lative to Ctrl group and presented as means± SE; n
= 4 rats/n = 20 cells per group; two-way ANOVA.
*P<0.05 vs. Ctrl rats; #P<0.05 SMT/N-acet-
ylcystein-treated vs. without treatment. Reprinted
with permission from Meyer et al. [120].
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precise biological origins of a given biomarker prior to an accurate
interpretation. For example whilst urinary 8-oxodGuo is widely as-
sumed to be a product of DNA repair, and as such reﬂective of DNA
oxidation, the precise source (ie 2′-deoxyribonucleotide pool or other-
wise) is not understood [154]. Another potentially problematic area is
interpreting the eﬀects of generic antioxidants such as NAC, many of
the observed eﬀects of which may be related to increasing thiol levels
within a cell or culture medium or changes in cell surface proteins ra-
ther than the direct scavenging of oxidants such as H2O2. Away from
the analytical approach to the experimental system applied, since cell
culture systems not only impose an OS per se, but also represent an
environment in which antioxidants are unstable, the likelihood that
further misleading data can easily be generated should be borne in
mind.
Much of the epidemiological support for a role of OS in inﬂuencing
cardiovascular outcomes stems from studies examining how anti-
oxidant defence pathways (polymorphisms in antioxidant genes, anti-
oxidant supplementation, PM oxidative potential) may modify the im-
pact of ambient pollutant exposure on health eﬀects. Studies, primarily
limited to the Normative Aging Study cohort of elderly Caucasian men,
have revealed an eﬀect modiﬁcation of the association between traﬃc
pollutants and markers of endothelial function, changes in HRV and risk
of acute cardiovascular disease by gene variants related to antioxidant
defenses [24,83–86,104]. Results from a smaller number of investiga-
tions into the interactions between such genetic polymorphisms and
urban air pollution for hypertension and markers of thrombosis and
Table 8
Studies linking air pollution exposure to metabolic disease mediated by oxidative stress.
Human
Study [reference] Population/design Air pollutant Main ﬁndings
Kim et al. [133] 560 elderly participants of Korean Elderly
Environmental Panel
Ambient PM10, NO2, O3 GSTM1-null, GSTT1-null, and GSTP1 AG or GG genotypes may
increase susceptibility of potential eﬀects of ambient air pollutants
on IR
Huang et al. [134] Controlled exposure UFP (50 μg/m3) 2 h Gene expression changes in circulating mononuclear cells; pathway
analysis identiﬁed IGF−1 and insulin receptor signaling and
including NRF2-mediated OS signaling
Animal
Study [reference] Animal model Air pollutant exposure Main ﬁndings (exposed versus control)
Xu et al. [135] C57BL/6 mice PM2.5 (~12.7 μg/m3)
6 h/d, 5 d/wk for 10 wk
Systemic and local IR, decreased glucose tolerance, inﬂammatory
response, oxidative stress (elevated 3-NT and increased Nrf2-
regulated antioxidant genes), mitochondrial dysfunction in brown
and white adipose tissue
Sun et al. [136] Sprague–Dawley rats fed high fructose diet
prior to exposure
CAPs (441 μg/m3) + O3 (0.497 ppm)
8 h/d, 5 d/wk, for 9 d over 2 wk
Inﬂammation and OS (increase iNOS protein expression), decreased
mitochondrial area in epicardial and perirenal adipose tissue
Xu et al. [137] C57BL/6 mice (wild type) versus
genetically modiﬁed mice (p47phox
homozygous knockout)
Early life (3 wk) exposure to PM2.5
(~111 μg/m3) 6 h/d, 5 d/wk for 10
wk





fed a high fat diet
PM2.5 CAPs (30–120 µg/m3) 6 h/d
for 9 or 30 d
Vascular insulin resistance and inﬂammation triggered in part by
pulmonary oxidative stress (increased expression of SOD2, SOD3
and GST-α)
Wei et al. [139] Pregnant Sprague Dawley and oﬀspring Pre (14d) and postnatal (3 or 8 wk)
exposure to unﬁltered Beijing PM2.5
(~73.5 μg/m3)
Pulmonary inﬂammation and increased tissue and systemic OS
(decreased GSH and increased MDA) contributes to increased
weight gain and metabolic dysfunction
Nemmar et al. [140] Tuck Ordinary mouse model of type 1
diabetes
IT DEP (0.4 mg/kg) Hypoxemia, hepatotoxicity, acceleration of coagulation, attributed
to increased systemic OS (increased plasma 8-isoprostane) and
inﬂammation
Zhong et al. [142] Diabetes-prone KK mice O3 (0.5 ppm) 4 h/d for 13 wk IR, inﬂammation, increased expression of OS-related genes (Cox4,
Cox5a, Scd1, Nrf1, Nrf2) in visceral adipose tissue
Vella et al. [141] Wistar rats O3 (0.8 ppm) overnight Whole-body insulin resistance and OS, associated endoplasmic
reticulum stress, JNK) activation, disruption of insulin signaling in
skeletal muscle.
Inhibition of insulin-stimulated glucose uptake in muscle cells
treated with BALF from O3-exposed rats; but not from BALF from
NAC treated O3-exposed rats
In vitro
Study [reference] Cells/tissue Air pollutant exposure Main ﬁndings (exposed versus control)
Mo et al. [146] Alveolar macrophages from rabbits with or
without DM
Urban PM (SRM 1648, 600 μg/ml) OS (DCFH-DA oxidation) in macrophages from DM rabbits and up-
regulation of cytokine expression and MMP−9 activity
Zhang et al. [147] Human monocytes Urban PM (SRM 1648, 600 μg/ml)
plus high glucose
Increased OS (DCFH-DA oxidation) phosphorylation of p38,
MMP−2 and MMP−9 mRNA expression and pro-MMP−2/pro-
MMP−9 activity compared with that of urban PM alone; use of
NAC, CAT and speciﬁc p38 inhibitor suggest activation of MMPs by
UFP within a high glucose setting is partly mediated via p38
phosphorylation induced by OS
3-NT: 3-nitrotyrosine; BALF: bronchoalveolar lavage ﬂuid; CAP: concentrated ambient particle; DCFH-DA: dichlorodihydroﬂuorescein diacetate; DEP: diesel exhaust particle; GSH:
reduced glutathione; GST: glutathione S-transferase; iNOS: inducible nitric oxide synthase; IR: insulin resistance; IT: intratracheal; JNK: c-Jun NH2-terminal kinases; MDA: mal-
ondialdehyde; NAC: N-acetylcysteine; NADPH: nicotinamide adenine dinucleotide phosphate, reduced; NO2: nitrogen dioxide; O3: ozone; OS: oxidative stress; PM: particulate matter;
PM2.5: particulate matter less than 2.5 µm in diameter; SOD: superoxide dismutase; UFP: ultraﬁne particle.
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coagulation have been more inconsistent [103,104]. Further evaluation
is therefore warranted, particularly for chronic cardiovascular out-
comes and in more generalized populations to broaden our under-
standing of susceptibilities to pollutant-induced health eﬀects. The few,
small scale studies that have explored potential eﬀect modiﬁcation by
either ﬁsh oil supplementation [95,96] or statins [83] again support the
role of OS in an ambient PM-induced decline in HRV. These studies are
supported by animal data, showing that pretreatment with antioxidants
or functional foods represents a valuable approach for the prevention of
DEP-induced thrombotic complications [79,80] – a caveat here how-
ever is that laboratory animals appear to be more responsive to dietary
antioxidants compared with humans [155]. More epidemiological stu-
dies, ideally incorporating mechanistic investigations, into such
beneﬁcial eﬀects are therefore needed since if nutritional supplements
and/or pharmacological agents can blunt the adverse health cardiac
eﬀects of air pollution exposure, populations residing in polluted urban
cities might be oﬀered at least some protection. This may be particu-
larly eﬀective for vulnerable individuals – for instance those genetically
susceptible to oxidative stress or people with underlying cardiovascular
conditions on the basis that there may in fact be some synergism be-
tween classical risk factors and DEP-induced OS [33].
Further work is also required to ascertain, for each of the cardio-
vascular endpoints discussed, whether enhanced OS triggers and/or
worsens the eﬀect and/or is representative of the consequence of dis-
ease progression. This may well depend upon the nature of the ambient
pollutant as well as the speciﬁc adverse cardiac event or susceptibility
Fig. 6. The antioxidant NAC prevented O3-induced disruption of insulin signaling pathways. Rats were given NAC (225 mg kg−1) for 10 days prior to O3 exposure. Insulin sensitivity was
explored using ITT. A: Blood glucose concentration was measured after intraperitoneal injection of insulin (0.5 IU/kg) in fasting rats, and plasma KITT was calculated. Results are
expressed as the mean± SEM for n = 5 rats. **P<0.01, ***P<0.005. Diﬀerent letters (a, b, and c) indicate a signiﬁcant diﬀerence at P<0.05. Carbonyl content in muscle and lung
(B), TBARS concentration (C), total protein concentration (D), and total cell count (E) in BALF (n= 5). **P<0.01, ***P<0.005. C2C12 myotubes were incubated for 30 min with BALF
(10%, v/v) from rats pretreated with NAC and exposed to O3, and stimulated by 100 nmol/L insulin for 20 min. Insulin-induced phosphorylation of PKB/Akt (F) and JNK (G) was
measured by Western blotting. Results are reported as the mean± SEM for n= 4. *P<0.05; **P<0.01; ***P<0.005. C.a., clean air; MW, molecular weight; ns, nonsigniﬁcant; O., O3;
P, phosphorylated. Reprinted with permission from Vella et al. [141].
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to associated conditions under question. For example if OS is a trigger
for the acceleration or exacerbation of pollution-induced athero-
sclerosis, signs of cellular oxidative imbalance should coincide with or
precede the atherosclerotic eﬀects. However, animal research em-
ploying weeks to months of inhalation exposures, very often undertake
OS and lesion development measures at the end of the study, making it
diﬃcult to determine the degree to which OS may initiate versus re-
present a consequence of the process. The contribution of OS pathways
to acute versus chronic cardiovascular disease following exposure to air
pollutants is also currently unclear. However it is unlikely to be an ei-
ther/or scenario. An acute oxidative insult could escalate into a cu-
mulative eﬀect following repeated environmental insults and/or pro-
voke end stage adverse outcomes in already chronic cardiac states. It is
highly likely that such questions are related to the substantial degree of
interconnectivity between the pro-oxidant and pro-inﬂammatory ef-
fects that occur following exposure and inhalation of ambient pollu-
tants and as such the diﬃculty in determining whether the induction of
vascular OS precedes or follows that of inﬂammation.
We can undoubtedly look forward to many more years of research in
this area, leading to a clearer and more precise deﬁnition of the role of
OS versus indeed other mechanisms. In the meantime, the collective
body of evidence emerging from multi-disciplinary work, continues to
support a role for OS in the fundamental machinery behind the devel-
opment of cardiovascular disease outcomes associated with ambient air
pollution.
Conﬂicts of interest
The authors declare no conﬂicts of interest.
Acknowledgements
This work was funded by the National Institute for Health Research
Health Protection Research Unit (NIHR HPRU) in Health Impacts of
Environmental Hazards at King’s College London in partnership with
Public Health England (PHE) (HPRU-2012-10030). The views ex-
pressed are those of the authors and not necessarily those of the NHS,
the NIHR, the Department of Health or Public Health England
References
[1] R.D. Brook, S. Rajagopalan, C.A. Pope 3rd, J.R. Brook, A. Bhatnagar, A.V. Diez-
Roux, F. Holguin, Y. Hong, R.V. Luepker, M.A. Mittleman, A. Peters, D. Siscovick,
S.C. Smith Jr., L. Whitsel, J.D. Kaufman, American Heart Association Advocacy
Coordinating Committee, Council on Epidemiology and Prevention, Council on the
Kidney in Cardiovascular Disease, Council on Nutrition, Physical Activity and
Metabolism, Particulate matter air pollution and cardiovascular disease: an update
to the scientiﬁc statement from the American Heart Association, Circulation 121
(21) (2010) 2331–2378.
[2] M. Franchini, P.M. Mannucci, Short-term eﬀects of air pollution on cardiovascular
diseases: outcomes and mechanisms, J. Thromb. Haemost. 5 (2007) 2169–2174.
[3] H. Mustaﬁc, P. Jabre, C. Caussin, M.H. Murad, S. Escolano, M. Taﬄet, M.-
C. Perier, E. Marijon, D. Vernerey, J.-P. Empana, X. Jouven, Main air pollutants
and myocardial infarction: a systematic review and meta-analysis, JAMA 307 (7)
(2012) 713–721.
[4] C.A. Pope, D.W. Dockery, Health eﬀects of ﬁne particulate air pollution: lines that
connect, J. Air Waste Manag. Assoc. 56 (6) (2006) 709–742.
[5] M.R. Miller, S.J. Borthwick, C.A. Shaw, S.G. McLean, D. McClure, N.L. Mills,
R. Duﬃn, K. Donaldson, I.L. Megson, P.W. Hadoke, D.E. Newby, Direct impair-
ment of vascular function by diesel exhaust particulate through reduced bioa-
vailability of endothelium-derived nitric oxide induced by superoxide free radi-
cals, Environ. Health Perspect. 117 (4) (2009) 611–616.
[6] P. Moller, L. Mikkelsen, L.K. Vesterdal, J.K. Folkmann, L. Forchhammer,
M. Roursgaard, P.H. Danielsen, S. Loft, Hazard identiﬁcation of particulate matter
Fig. 7. Illustration of potential oxidative stress-mediated mechanisms for eﬀect of ambient air pollution on cardiovascular diseases. Observations in association with oxidative stress (eg
increased oxidant production; attenuation/reversal of eﬀect in the presence of antioxidants/use of transgenic models; eﬀect modiﬁcation by polymorphisms in antioxidant genes; genetic
pathway analysis) originate from epidemiological and experimental ﬁndings described in this review. AT1R: angiotensin II receptor type 1; BMSC: bone marrow stem cells; CVD:
cardiovascular disease susceptibility; EPC: endothelial progenitor cell; HDL: high density lipoprotein; HRV: heart rate variability; IR: insulin resistance; MMP: matrix metalloproteinases;
NO: nitric oxide; NOS: nitric oxide synthase; oxo-LDL: oxidized low density lipoprotein; PAI-1: plasminogen activator inhibitor-1; sCD36: soluble CD36 receptor; TF: tissue factor; tPA:
tissue plasminogen factor; vWF: von Willebrand factor.
F.J. Kelly, J.C. Fussell Free Radical Biology and Medicine 110 (2017) 345–367
363
on vasomotor dysfunction and progression of atherosclerosis, Crit. Rev. Toxicol.
41 (4) (2011) 339–368.
[7] M.R. Miller, The role of oxidative stress in the cardiovascular actions of particulate
air pollution, Biochem Soc. Trans. 42 (4) (2014) 1006–1011.
[8] C.M. Perez, M.S. Hazari, A.K. Farraj, Role of autonomic reﬂex arcs in cardiovas-
cular responses to air pollution exposure, Cardiovasc Toxicol. 15 (1) (2015)
69–78.
[9] M.R. Miller, C.A. Shaw, J.P. Langrish, From particles to patients: oxidative stress
and the cardiovascular eﬀects of air pollution, Future Cardiol. 8 (4) (2012)
577–602.
[10] R.J. Delﬁno, N. Staimer, N.D. Vaziri, Air pollution and circulating biomarkers of
oxidative stress, Air Qual. Atmos. Health 4 (1) (2011) 37–52.
[11] S.A. Weichenthal, K. Godri-Pollitt, P.J. Villeneuve, PM2.5, oxidant defence and
cardiorespiratory health: a review, Environ. Health 12 (2013) 40.
[12] R.D. Brook, S. Rajagopalan, Particulate matter, air pollution, and blood pressure,
J. Am. Soc. Hypertens. 3 (5) (2009) 332–350.
[13] H.C. Chuang, T.W. Hsueh, C.C. Chang, J.S. Hwang, K.J. Chuang, Y.H. Yan,
T.J. Cheng, Nickel-regulated heart rate variability: the roles of oxidative stress and
inﬂammation, Toxicol. Appl. Pharmacol. 266 (2) (2013) 298–306.
[14] P. Moller, D.V. Christophersen, N.R. Jacobsen, A. Skovmand, A.C. Gouveia,
M.H. Andersen, A. Kermanizadeh, D.M. Jensen, P.H. Danielsen, M. Roursgaard,
K. Jantzen, S. Loft, Atherosclerosis and vasomotor dysfunction in arteries of ani-
mals after exposure to combustion-derived particulate matter or nanomaterials,
Crit. Rev. Toxicol. (2016) 1–40.
[15] U. Alheid, J.C. Frolich, U. Forstermann, Endothelium derived relaxing factor from
cultured human endothelial cells inhibits aggregation of human platelets, Thromb.
Res. 47 (1987) 561–571.
[16] P. Kubes, M. Suzuki, D.N. Granger, Nitric oxide: an endogenous modulator of
leukocyte adhesion, Proc. Natl. Acad. Sci. 88 (1991) 4651–4655.
[17] Y. ￼Nunokawa, S. Tanaka, Interferon-γ inhibits proligeration of rat smooth muscle
cells by nitric oxide generation, Biochem Biophys. Res Commun. 188 (1) (1992)
409–415.
[18] T.J. Anderson, M.D. Gerhard, I.T. Meredith, F. Charbonneau, D. Delagrange,
M.A. Creager, A.P. Selwyn, P. Ganz, Systemic nature of endothelial dysfunction in
atherosclerosis, Am. J. Cardiol. 75 (1995) 71B–74B.
[19] E.O. Apostolov, S.V. Shah, E. Ok, A.G. Basnakian, Carbamylated low-density li-
poprotein induces monocyte adhesion to endothelial cells through intercellular
adhesion molecule-1 and vascular cell adhesion molecule-1, Arterioscler. Thromb.
Vasc. Biol. 27 (4) (2007) 826–832.
[20] P. Libby, P.M. Ridker, G.K. Hansson, Progress and challenges in translating the
biology of atherosclerosis, Nature 473 (7347) (2011) 317–325.
[21] K.J. Moore, F.J. Sheedy, E.A. Fisher, Macrophages in atherosclerosis: a dynamic
balance, Nat. Rev. Immunol. 13 (10) (2013) 709–721.
[22] T. Cherng, M. Paﬀett, O. Jackson-Weaver, M. Campen, B. Walker, K. NL,
Mechanisms of diesel-induced endothelial nitric oxide synthase dysfunction in
coronary arterioles, Environ. Health Perspect. 119 (2011) 98–103.
[23] R. Radi, Peroxynitrite, a stealthy biological oxidant, J. Biol. Chem. 288 (37)
(2013) 26464–26472.
[24] J. Madrigano, A. Baccarelli, R.O. Wright, H. Suh, D. Sparrow, P.S. Vokonas,
J. Schwartz, Air pollution, obesity, genes and cellular adhesion molecules, Occup.
Environ. Med 67 (5) (2010) 312–317.
[25] M.A. Bind, B. Coull, H. Suh, R. Wright, A. Baccarelli, P. Vokonas, J. Schwartz, A
novel genetic score approach using instruments to investigate interactions be-
tween pathways and environment: application to air pollution, PLoS One 9 (4)
(2014) e96000.
[26] L. Dai, M.A. Bind, P. Koutrakis, B.A. Coull, D. Sparrow, P.S. Vokonas,
J.D. Schwartz, Fine particles, genetic pathways, and markers of inﬂammation and
endothelial dysfunction: analysis on particulate species and sources, J. Expo. Sci.
Environ. Epidemiol. 26 (4) (2016) 415–421.
[27] X. Zhang, N. Staimer, T. Tjoa, D.L. Gillen, J.J. Schauer, M.M. Shafer,
S. Hasheminassab, P. Pakbin, J. Longhurst, C. Sioutas, R.J. Delﬁno, Associations
between microvascular function and short-term exposure to traﬃc-related air
pollution and particulate matter oxidative potential, Environ. Health 15 (1)
(2016) 81.
[28] A. Wauters, C. Dreyfuss, S. Pochet, P. Hendrick, G. Berkenboom, P. van de Borne,
J.F. Argacha, Acute exposure to diesel exhaust impairs nitric oxide-mediated en-
dothelial vasomotor function by increasing endothelial oxidative stress,
Hypertension 62 (2) (2013) 352–358.
[29] Z. Ying, X. Xu, M. Chen, D. Liu, M. Zhong, L.C. Chen, Q. Sun, S. Rajagopalan, A
synergistic vascular eﬀect of airborne particulate matter and nickel in a mouse
model, Toxicol. Sci. 135 (1) (2013) 72–80.
[30] T. Kampfrath, A. Maiseyeu, Z. Ying, Z. Shah, J.A. Deiuliis, X. Xu, N. Kherada,
R.D. Brook, K.M. Reddy, N.P. Padture, S. Parthasarathy, L.C. Chen, S. Moﬀatt-
Bruce, Q. Sun, H. Morawietz, S. Rajagopalan, Chronic ﬁne particulate matter ex-
posure induces systemic vascular dysfunction via NADPH oxidase and TLR4
pathways, Circ. Res 108 (6) (2011) 716–726.
[31] A.K. Lund, J. Lucero, S. Lucas, M.C. Madden, J.D. McDonald, J.C. Seagrave,
T.L. Knuckles, M.J. Campen, Vehicular emissions induce vascular MMP-9 ex-
pression and activity associated with endothelin-1-mediated pathways,
Arterioscler. Thromb. Vasc. Biol. 29 (4) (2009) 511–517.
[32] A.K. Lund, J. Lucero, M. Harman, M.C. Madden, J.D. McDonald, J.C. Seagrave,
M.J. Campen, The oxidized low-density lipoprotein receptor mediates vascular
eﬀects of inhaled vehicle emissions, Am. J. Respir. Crit. Care Med. 184 (1) (2011)
82–91.
[33] N. Labranche, C. El Khattabi, L. Dewachter, C. Dreyfuss, J. Fontaine, P. van de
Borne, G. Berkenboom, S. Pochet, Vascular oxidative stress induced by diesel
exhaust microparticles: synergism with hypertension, J. Cardiovasc. Pharmacol.
60 (6) (2012) 530–537.
[34] H. Li, M. Han, L. Guo, G. Li, N. Sang, Oxidative stress, endothelial dysfunction and
inﬂammatory response in rat heart to NO(2) inhalation exposure, Chemosphere 82
(11) (2011) 1589–1596.
[35] G.C. Chuang, Z. Yang, D.G. Westbrook, M. Pompilius, C.A. Ballinger, C.R. White,
D.M. Krzywanski, E.M. Postlethwait, S.W. Ballinger, Pulmonary ozone exposure
induces vascular dysfunction, mitochondrial damage, and atherogenesis, Am. J.
Physiol. Lung Cell Mol. Physiol. 297 (2) (2009) L209–L216.
[36] U.P. Kodavanti, R. Thomas, A.D. Ledbetter, M.C. Schladweiler, J.H. Shannahan,
J.G. Wallenborn, A.K. Lund, M.J. Campen, E.O. Butler, R.R. Gottipolu, A. Nyska,
J.E. Richards, D. Andrews, R.H. Jaskot, J. McKee, S.R. Kotha, R.B. Patel,
N.L. Parinandi, Vascular and cardiac impairments in rats inhaling ozone and diesel
exhaust particles, Environ. Health Perspect. 119 (3) (2011) 312–318.
[37] M.L. Paﬀett, K.E. Zychowski, L. Sheppard, S. Robertson, J.M. Weaver, S.N. Lucas,
M.J. Campen, Ozone inhalation impairs coronary artery dilation via intracellular
oxidative stress: evidence for serum-borne factors as drivers of systemic toxicity,
Toxicol. Sci. 146 (2) (2015) 244–253.
[38] P. Haberzettl, J. Lee, D. Duggineni, J. McCracken, D. Bolanowski, T.E. O'Toole,
A. Bhatnagar, D.J. Conklin, Exposure to ambient air ﬁne particulate matter pre-
vents VEGF-induced mobilization of endothelial progenitor cells from the bone
marrow, Environ. Health Perspect. 120 (6) (2012) 848–856.
[39] T.E. O'Toole, J. Hellmann, L. Wheat, P. Haberzettl, J. Lee, D.J. Conklin,
A. Bhatnagar, C.A. Pope 3rd, Episodic exposure to ﬁne particulate air pollution
decreases circulating levels of endothelial progenitor cells, Circ. Res. 107 (2)
(2010) 200–203.
[40] Y. Cui, F. Jia, J. He, X. Xie, Z. Li, M. Fu, H. Hao, Y. Liu, D.Z. Liu, P.J. Cowan,
H. Zhu, Q. Sun, Z. Liu, Ambient ﬁne particulate matter suppresses in vivo pro-
liferation of bone marrow stem cells through reactive oxygen species formation,
PLoS One 10 (6) (2015) e0127309.
[41] Y. Cui, X. Xie, F. Jia, J. He, Z. Li, M. Fu, H. Hao, Y. Liu, J.Z. Liu, P.J. Cowan,
H. Zhu, Q. Sun, Z. Liu, Ambient ﬁne particulate matter induces apoptosis of en-
dothelial progenitor cells through reactive oxygen species formation, Cell Physiol.
Biochem. 35 (1) (2015) 353–363.
[42] H. Wei, W. Dan, Y. Shuo, Z. Fang, D. Wenjun, Oxidative stress induced by urban
ﬁne particles in cultured EA.hy926 cells, Hum. Exp. Toxicol. 30 (7) (2011)
579–590.
[43] L. Forchhammer, S. Loft, M. Roursgaard, Y. Cao, I.S. Riddervold, T. Sigsgaard,
P. Moller, Expression of adhesion molecules, monocyte interactions and oxidative
stress in human endothelial cells exposed to wood smoke and diesel exhaust
particulate matter, Toxicol. Lett. 209 (2) (2012) 121–128.
[44] A. Montiel-Davalos, A. Gonzalez-Villava, V. Rodriguez-Lara, L.F. Montano,
T.I. Fortoul, R. Lopez-Marure, Vanadium pentoxide induces activation and death
of endothelial cells, J. Appl. Toxicol. 32 (1) (2012) 26–33.
[45] N. Buchner, N. Ale-Agha, S. Jakob, U. Sydlik, K. Kunze, K. Unfried, J. Altschmied,
J. Haendeler, Unhealthy diet and ultraﬁne carbon black particles induce senes-
cence and disease associated phenotypic changes, Exp. Gerontol. 48 (1) (2013)
8–16.
[46] Y. Cao, M. Roursgaard, P.H. Danielsen, P. Moller, S. Loft, Carbon black nano-
particles promote endothelial activation and lipid accumulation in macrophages
independently of intracellular ROS production, PLoS One 9 (9) (2014) e106711.
[47] W. Rui, L. Guan, F. Zhang, W. Zhang, W. Ding, PM2.5 -induced oxidative stress
increases adhesion molecules expression in human endothelial cells through the
ERK/AKT/NF-kappaB-dependent pathway, J. Appl. Toxicol. 36 (1) (2016) 48–59.
[48] R. Li, Z. Ning, J. Cui, B. Khalsa, L. Ai, W. Takabe, T. Beebe, R. Majumdar,
C. Sioutas, T. Hsiai, Ultraﬁne particles from diesel engines induce vascular oxi-
dative stress via JNK activation, Free Radic. Biol. Med. 46 (6) (2009) 775–782.
[49] Y. Du, M. Navab, M. Shen, J. Hill, P. Pakbin, C. Sioutas, T.K. Hsiai, R. Li, Ambient
ultraﬁne particles reduce endothelial nitric oxide production via S-glutathionyla-
tion of eNOS, Biochem Biophys. Res. Commun. 436 (3) (2013) 462–466.
[50] Y. Mo, R. Wan, S. Chien, D.J. Tollerud, Q. Zhang, Activation of endothelial cells
after exposure to ambient ultraﬁne particles: the role of NADPH oxidase, Toxicol.
Appl. Pharmacol. 236 (2) (2009) 183–193.
[51] H. Frikke-Schmidt, M. Roursgaard, J. Lykkesfeldt, S. Loft, J.K. Nojgaard, P. Moller,
Eﬀect of vitamin C and iron chelation on diesel exhaust particle and carbon black
induced oxidative damage and cell adhesion molecule expression in human en-
dothelial cells, Toxicol. Lett. 203 (3) (2011) 181–189.
[52] C.C. Lee, S.H. Huang, Y.T. Yang, Y.W. Cheng, C.H. Li, J.J. Kang, Motorcycle ex-
haust particles up-regulate expression of vascular adhesion molecule-1 and in-
tercellular adhesion molecule-1 in human umbilical vein endothelial cells, Toxicol.
Vitr. 26 (4) (2012) 552–560.
[53] C.Y. Tseng, J.F. Chang, J.S. Wang, Y.J. Chang, M.K. Gordon, M.W. Chao,
Protective Eﬀects of N-acetyl cysteine against diesel exhaust particles-induced
intracellular ROS generates pro-inﬂammatory cytokines to mediate the vascular
permeability of capillary-like endothelial tubes, PLoS One 10 (7) (2015)
e0131911.
[54] J.F. Viles-Gonzalez, V. Fuster, J.J. Badimon, Atherothrombosis: a widespread
disease with unpredictable and life-threatening consequences, Eur. Heart J. 25
(14) (2004) 1197–1207.
[55] E. Podrez, M. Febbraio, N. Sheibani, D. Schmitt, R. Silverstein, D. Hajjar, P. Cohen,
W. Frazier, H. Hoﬀ, S. Hazen, Macrophage scavenger receptor CD36 is the major
receptor for LDL modiﬁed by monocyte-generated reactive nitrogen species, J.
Clin. Investig. 105 (2000) 1095–1108.
[56] E. Zakynthinos, N. Pappa, Inﬂammatory biomarkers in coronary artery disease, J.
Cardiol. 53 (3) (2009) 317–333.
[57] J.A. Araujo, A.E. Nel, Particulate matter and atherosclerosis: role of particle size,
F.J. Kelly, J.C. Fussell Free Radical Biology and Medicine 110 (2017) 345–367
364
composition and oxidative stress, Part Fibre Toxicol. 6 (2009) 24.
[58] S. Wu, D. Yang, H. Wei, B. Wang, J. Huang, H. Li, M. Shima, F. Deng, X. Guo,
Association of chemical constituents and pollution sources of ambient ﬁne parti-
culate air pollution and biomarkers of oxidative stress associated with athero-
sclerosis: a panel study among young adults in Beijing, China, Chemosphere 135
(2015) 347–353.
[59] R. Kelishadi, N. Mirghaﬀari, P. Poursafa, S.S. Gidding, Lifestyle and environmental
factors associated with inﬂammation, oxidative stress and insulin resistance in
children, Atherosclerosis 203 (1) (2009) 311–319.
[60] L. Jacobs, J. Emmerechts, C. Mathieu, M.F. Hoylaerts, F. Fierens, P.H. Hoet,
B. Nemery, T.S. Nawrot, Air pollution related prothrombotic changes in persons
with diabetes, Environ. Health Perspect. 118 (2) (2010) 191–196.
[61] N. Brucker, A.M. Moro, M.F. Charao, J. Durgante, F. Freitas, M. Baierle,
S. Nascimento, B. Gauer, R.P. Bulcao, G.B. Bubols, P.D. Ferrari, F.V. Thiesen,
A. Gioda, M.M. Duarte, I. de Castro, P.H. Saldiva, S.C. Garcia, Biomarkers of oc-
cupational exposure to air pollution, inﬂammation and oxidative damage in taxi
drivers, Sci. Total Environ. 463–464 (2013) 884–893.
[62] C. Tonne, J.D. Yanosky, S. Beevers, P. Wilkinson, F.J. Kelly, PM mass concentra-
tion and PM oxidative potential in relation to carotid intima-media thickness,
Epidemiology 23 (3) (2012) 486–494.
[63] R.S. Rodosthenous, B.A. Coull, Q. Lu, P.S. Vokonas, J.D. Schwartz, A.A. Baccarelli,
Ambient particulate matter and microRNAs in extracellular vesicles: a pilot study
of older individuals, Part Fibre Toxicol. 13 (1) (2016) 13.
[64] Q. Sun, A. Wang, X. Jin, A. Natanzon, D. Duquaine, R.D. Brook, J.-G.S. Aguinaldo,
Z.A. Fayad, V. Fuster, M. Lippmann, L.C. Chen, S. Rajagopalan, Long-term air
pollution exposure and acceleration of atherosclerosis and vascular inﬂammation
in an animal model, JAMA 294 (23) (2005) 3003–3010.
[65] A.K. Lund, T.L. Knuckles, C. Obot Akata, R. Shohet, J.D. McDonald, A. Gigliotti,
J.C. Seagrave, M.J. Campen, Gasoline exhaust emissions induce vascular re-
modeling pathways involved in atherosclerosis, Toxicol. Sci. 95 (2) (2007)
485–494.
[66] N. Bai, T. Kido, H. Suzuki, G. Yang, T.J. Kavanagh, J.D. Kaufman, M.E. Rosenfeld,
C. van Breemen, S.F. Eeden, Changes in atherosclerotic plaques induced by in-
halation of diesel exhaust, Atherosclerosis 216 (2) (2011) 299–306.
[67] M.R. Miller, S.G. McLean, R. Duﬃn, A.O. Lawal, J.A. Araujo, C.A. Shaw, N.L. Mills,
K. Donaldson, D.E. Newby, P.W. Hadoke, Diesel exhaust particulate increases the
size and complexity of lesions in atherosclerotic mice, Part Fibre Toxicol. 10
(2013) 61.
[68] F. Yin, A. Lawal, J. Ricks, J.R. Fox, T. Larson, M. Navab, A.M. Fogelman,
M.E. Rosenfeld, J.A. Araujo, Diesel exhaust induces systemic lipid peroxidation
and development of dysfunctional pro-oxidant and pro-inﬂammatory high-density
lipoprotein, Arterioscler. Thromb. Vasc. Biol. 33 (6) (2013) 1153–1161.
[69] R. Li, M. Navab, P. Pakbin, Z. Ning, K. Navab, G. Hough, T.E. Morgan, C.E. Finch,
J.A. Araujo, A.M. Fogelman, C. Sioutas, T. Hsiai, Ambient ultraﬁne particles alter
lipid metabolism and HDL anti-oxidant capacity in LDLR-null mice, J. Lipid Res 54
(6) (2013) 1608–1615.
[70] Z. Ying, T. Kampfrath, G. Thurston, B. Farrar, M. Lippmann, A. Wang, Q. Sun,
L.C. Chen, S. Rajagopalan, Ambient particulates alter vascular function through
induction of reactive oxygen and nitrogen species, Toxicol. Sci. 111 (1) (2009)
80–88.
[71] A. Montiel-Davalos, J. Ibarra-Sanchez Mde, J.L. Ventura-Gallegos, E. Alfaro-
Moreno, R. Lopez-Marure, Oxidative stress and apoptosis are induced in human
endothelial cells exposed to urban particulate matter, Toxicol. Vitr. 24 (1) (2010)
135–141.
[72] Q. Sun, P. Yue, Z. Ying, A.J. Cardounel, R.D. Brook, R. Devlin, J.S. Hwang,
J.L. Zweier, L.C. Chen, S. Rajagopalan, Air pollution exposure potentiates hy-
pertension through reactive oxygen species-mediated activation of Rho/ROCK,
Arterioscler. Thromb. Vasc. Biol. 28 (10) (2008) 1760–1766.
[73] Y. Cao, K. Jantzen, A.C. Gouveia, A. Skovmand, M. Roursgaard, S. Loft, P. Moller,
Automobile diesel exhaust particles induce lipid droplet formation in macrophages
in vitro, Environ. Toxicol. Pharmacol. 40 (1) (2015) 164–171.
[74] R.J. Delﬁno, N. Staimer, T. Tjoa, D.L. Gillen, A. Polidori, M. Arhami,
M.T. Kleinman, N.D. Vaziri, J. Longhurst, C. Sioutas, Air pollution exposures and
circulating biomarkers of eﬀect in a susceptible population: clues to potential
causal component mixtures and mechanisms, Environ. Health Perspect. 117 (8)
(2009) 1232–1238.
[75] A.P. Pettit, A. Brooks, R. Laumbach, N. Fiedler, Q. Wang, P.O. Strickland,
K. Madura, J. Zhang, H.M. Kipen, Alteration of peripheral blood monocyte gene
expression in humans following diesel exhaust inhalation, Inhal. Toxicol. 24 (3)
(2012) 172–181.
[76] R.B. Devlin, C.B. Smith, M.T. Schmitt, A.G. Rappold, A. Hinderliter, D. Graﬀ,
M.S. Carraway, Controlled exposure of humans with metabolic syndrome to
concentrated ultraﬁne ambient particulate matter causes cardiovascular eﬀects,
Toxicol. Sci. 140 (1) (2014) 61–72.
[77] M. Strak, G. Hoek, K.J. Godri, I. Gosens, I.S. Mudway, R. van Oerle, H.M. Spronk,
F.R. Cassee, E. Lebret, F.J. Kelly, R.M. Harrison, B. Brunekreef, M. Steenhof,
N.A. Janssen, Composition of PM aﬀects acute vascular inﬂammatory and coa-
gulative markers – the RAPTES project, PLoS One 8 (3) (2013) e58944.
[78] S. Upadhyay, T. Stoeger, L. George, M.C. Schladweiler, U. Kodavanti, K. Ganguly,
H. Schulz, Ultraﬁne carbon particle mediated cardiovascular impairment of aged
spontaneously hypertensive rats, Part Fibre Toxicol. 11 (2014) 36.
[79] A. Nemmar, S. Al-Salam, S. Dhanasekaran, M. Sudhadevi, B.H. Ali, Pulmonary
exposure to diesel exhaust particles promotes cerebral microvessel thrombosis:
protective eﬀect of a cysteine prodrug l-2-oxothiazolidine-4-carboxylic acid,
Toxicology 263 (2–3) (2009) 84–92.
[80] A. Nemmar, R. Al Dhaheri, J. Alamiri, S. Al Hefeiti, H. Al Saedi, S. Beegam,
P. Yuvaraju, J. Yasin, B.H. Ali, Diesel exhaust particles induce impairment of
vascular and cardiac homeostasis in mice: ameliorative eﬀect of emodin, Cell
Physiol. Biochem. 36 (4) (2015) 1517–1526.
[81] S.J. Snow, W. Cheng, A.S. Wolberg, M.S. Carraway, Air pollution upregulates
endothelial cell procoagulant activity via ultraﬁne particle-induced oxidant sig-
naling and tissue factor expression, Toxicol. Sci. 140 (1) (2014) 83–93.
[82] S.E. Chiarella, S. Soberanes, D. Urich, L. Morales-Nebreda, R. Nigdelioglu,
D. Green, J.B. Young, A. Gonzalez, C. Rosario, A.V. Misharin, A.J. Ghio,
R.G. Wunderink, H.K. Donnelly, K.A. Radigan, H. Perlman, N.S. Chandel,
G.R. Budinger, G.M. Mutlu, beta(2)-Adrenergic agonists augment air pollution-
induced IL-6 release and thrombosis, J. Clin. Invest. 124 (7) (2014) 2935–2946.
[83] J. Schwartz, S.K. Park, M.S. O'Neill, P.S. Vokonas, D. Sparrow, S. Weiss, K. Kelsey,
Glutathione-S-transferase M1, obesity, statins, and autonomic eﬀects of particles:
gene-by-drug-by-environment interaction, Am. J. Respir. Crit. Care Med. 172 (12)
(2005) 1529–1533.
[84] S.K. Park, M.S. O'Neill, R.O. Wright, H. Hu, P.S. Vokonas, D. Sparrow, H. Suh,
J. Schwartz, HFE genotype, particulate air pollution, and heart rate variability: a
gene-environment interaction, Circulation 114 (25) (2006) 2798–2805.
[85] T. Chahine, A. Baccarelli, A. Litonjua, R.O. Wright, H. Suh, D.R. Gold, D. Sparrow,
P. Vokonas, J. Schwartz, Particulate air pollution, oxidative stress genes, and heart
rate variability in an elderly cohort, Environ. Health Perspect. 115 (11) (2007)
1617–1622.
[86] E.S. Baja, J.D. Schwartz, G.A. Wellenius, B.A. Coull, A. Zanobetti, P.S. Vokonas,
H.H. Suh, Traﬃc-related air pollution and QT interval: modiﬁcation by diabetes,
obesity, and oxidative stress gene polymorphisms in the normative aging study,
Environ. Health Perspect. 118 (6) (2010) 840–846.
[87] K.N. Kim, J.H. Kim, K. Jung, Y.C. Hong, Associations of air pollution exposure with
blood pressure and heart rate variability are modiﬁed by oxidative stress genes: a
repeated-measures panel among elderly urban residents, Environ. Health 15 (1)
(2016) 47.
[88] M. Wang, M.J. Utell, A. Schneider, W. Zareba, M.W. Frampton, D. Oakes,
P.K. Hopke, J. Wiltshire, C. Kane, A. Peters, S. Breitner, D. Chalupa, D.Q. Rich,
Does total antioxidant capacity modify adverse cardiac responses associated with
ambient ultraﬁne, accumulation mode, and ﬁne particles in patients undergoing
cardiac rehabilitation? Environ. Res 149 (2016) 15–22.
[89] L.Y. Lin, H.C. Chuang, I.J. Liu, H.W. Chen, K.J. Chuang, Reducing indoor air
pollution by air conditioning is associated with improvements in cardiovascular
health among the general population, Sci. Total Environ. 463–464 (2013)
176–181.
[90] J. Zhang, T. Zhu, H. Kipen, G. Wang, W. Huang, D. Rich, P. Zhu, Y. Wang, S.E. Lu,
P. Ohman-Strickland, S. Diehl, M. Hu, J. Tong, J. Gong, D. Thomas,
Cardiorespiratory biomarker responses in healthy young adults to drastic air
quality changes surrounding the 2008 Beijing Olympics, Res Rep. Health Eﬀ. Inst.
174 (2013) 5–174.
[91] M.S. Lee, K.D. Eum, S.C. Fang, E.G. Rodrigues, G.A. Modest, D.C. Christiani,
Oxidative stress and systemic inﬂammation as modiﬁers of cardiac autonomic
responses to particulate air pollution, Int J. Cardiol. 176 (1) (2014) 166–170.
[92] J.A. Sarnat, R. Golan, R. Greenwald, A.U. Raysoni, P. Kewada, A. Winquist,
S.E. Sarnat, W. Dana Flanders, M.C. Mirabelli, J.E. Zora, M.H. Bergin, F. Yip,
Exposure to traﬃc pollution, acute inﬂammation and autonomic response in a
panel of car commuters, Environ. Res 133 (2014) 66–76.
[93] J.G. Hemmingsen, J. Rissler, J. Lykkesfeldt, G. Sallsten, J. Kristiansen, P.P. Moller,
S. Loft, Controlled exposure to particulate matter from urban street air is asso-
ciated with decreased vasodilation and heart rate variability in overweight and
older adults, Part Fibre Toxicol. 12 (2015) 6.
[94] H.M. Byun, E. Colicino, L. Trevisi, T. Fan, D.C. Christiani, A.A. Baccarelli, Eﬀects
of air pollution and blood mitochondrial DNA methylation on markers of heart
rate variability, J. Am. Heart Assoc. 5 (4) (2016).
[95] I. Romieu, M.M. Tellez-Rojo, M. Lazo, A. Manzano-Patino, M. Cortez-Lugo,
P. Julien, M.C. Belanger, M. Hernandez-Avila, F. Holguin, Omega-3 fatty acid
prevents heart rate variability reductions associated with particulate matter, Am.
J. Respir. Crit. Care Med. 172 (12) (2005) 1534–1540.
[96] H. Tong, A.G. Rappold, D. Diaz-Sanchez, S.E. Steck, J. Berntsen, W.E. Cascio,
R.B. Devlin, J.M. Samet, Omega-3 fatty acid supplementation appears to attenuate
particulate air pollution-induced cardiac eﬀects and lipid changes in healthy
middle-aged adults, Environ. Health Perspect. 120 (7) (2012) 952–957.
[97] E. Ghelﬁ, G.A. Wellenius, J. Lawrence, E. Millet, B. Gonzalez-Flecha, Cardiac
oxidative stress and dysfunction by ﬁne concentrated ambient particles (CAPs) are
mediated by angiotensin-II, Inhal. Toxicol. 22 (11) (2010) 963–972.
[98] J.B. Kim, C. Kim, E. Choi, S. Park, H. Park, H.N. Pak, M.H. Lee, D.C. Shin,
K.C. Hwang, B. Joung, Particulate air pollution induces arrhythmia via oxidative
stress and calcium calmodulin kinase II activation, Toxicol. Appl. Pharmacol. 259
(1) (2012) 66–73.
[99] S. Robertson, A.L. Thomson, R. Carter, H.R. Stott, C.A. Shaw, P.W. Hadoke,
D.E. Newby, M.R. Miller, G.A. Gray, Pulmonary diesel particulate increases sus-
ceptibility to myocardial ischemia/reperfusion injury via activation of sensory
TRPV1 and beta1 adrenoreceptors, Part Fibre Toxicol. 11 (2014) 12.
[100] G. Wang, R. Jiang, Z. Zhao, W. Song, Eﬀects of ozone and ﬁne particulate matter
(PM(2.5)) on rat system inﬂammation and cardiac function, Toxicol. Lett. 217 (1)
(2013) 23–33.
[101] L. Andre, F. Gouzi, J. Thireau, G. Meyer, J. Boissiere, M. Delage, A. Abdellaoui,
C. Feillet-Coudray, G. Fouret, J.P. Cristol, A. Lacampagne, P. Obert, C. Reboul,
J. Fauconnier, M. Hayot, S. Richard, O. Cazorla, Carbon monoxide exposure en-
hances arrhythmia after cardiac stress: involvement of oxidative stress, Basic Res.
Cardiol. 106 (6) (2011) 1235–1246.
[102] Z. Ying, P. Yue, X. Xu, M. Zhong, Q. Sun, M. Mikolaj, A. Wang, R.D. Brook,
F.J. Kelly, J.C. Fussell Free Radical Biology and Medicine 110 (2017) 345–367
365
L.C. Chen, S. Rajagopalan, Air pollution and cardiac remodeling: a role for RhoA/
Rho-kinase, Am. J. Physiol. Heart Circ. Physiol. 296 (5) (2009) H1540–H1550.
[103] I. Mordukhovich, E. Wilker, H. Suh, R. Wright, D. Sparrow, P.S. Vokonas,
J. Schwartz, Black carbon exposure, oxidative stress genes, and blood pressure in a
repeated-measures study, Environ. Health Perspect. 117 (11) (2009) 1767–1772.
[104] A. Levinsson, A.C. Olin, L. Modig, S. Dahgam, L. Bjorck, A. Rosengren, F. Nyberg,
Interaction eﬀects of long-term air pollution exposure and variants in the GSTP1,
GSTT1 and GSTCD genes on risk of acute myocardial infarction and hypertension:
a case-control study, PLoS One 9 (6) (2014) e99043.
[105] J. Zhong, A. Cayir, L. Trevisi, M. Sanchez-Guerra, X. Lin, C. Peng, M.A. Bind,
D. Prada, H. Laue, K.J. Brennan, A. Dereix, D. Sparrow, P. Vokonas, J. Schwartz,
A.A. Baccarelli, Traﬃc-Related Air Pollution, Blood Pressure, and Adaptive
Response of Mitochondrial Abundance, Circulation 133 (4) (2016) 378–387.
[106] V.C. Louwies T, L. Panis, B. Cox, K. Vrijens, T. Nawrot, P. De Boever, MiRNA
expression proﬁles and retinal blood vessel calibers are associated with short-term
particulate matter air pollution exposure, Environ. Res. 147 (2016) 24–31.
[107] R.R. Gottipolu, J.G. Wallenborn, E.D. Karoly, M.C. Schladweiler, A.D. Ledbetter,
T. Krantz, W.P. Linak, A. Nyska, J.A. Johnson, R. Thomas, J.E. Richards,
R.H. Jaskot, U.P. Kodavanti, One-month diesel exhaust inhalation produces hy-
pertensive gene expression pattern in healthy rats, Environ. Health Perspect. 117
(1) (2009) 38–46.
[108] O.G. Aztatzi-Aguilar, M. Uribe-Ramirez, J.A. Arias-Montano, O. Barbier, A. De
Vizcaya-Ruiz, Acute and subchronic exposure to air particulate matter induces
expression of angiotensin and bradykinin-related genes in the lungs and heart:
angiotensin-ii type-I receptor as a molecular target of particulate matter exposure,
Part Fibre Toxicol. 12 (2015) 17.
[109] C. Ren, S.K. Park, P.S. Vokonas, D. Sparrow, E. Wilker, A. Baccarelli, H.H. Suh,
K.L. Tucker, R.O. Wright, J. Schwartz, Air pollution and homocysteine: more
evidence that oxidative stress-related genes modify eﬀects of particulate air pol-
lution, Epidemiology 21 (2) (2010) 198–206.
[110] V.C. Van Hee, S.D. Adar, A.A. Szpiro, R.G. Barr, D.A. Bluemke, A.V. Diez Roux,
E.A. Gill, L. Sheppard, J.D. Kaufman, Exposure to traﬃc and left ventricular mass
and function: the Multi-Ethnic Study of Atherosclerosis, Am. J. Respir. Crit. Care
Med. 179 (9) (2009) 827–834.
[111] V.C. Van Hee, S.D. Adar, A.A. Szpiro, R.G. Barr, A. Diez Roux, D.A. Bluemke,
L. Sheppard, E.A. Gill, H. Bahrami, C. Wassel, M.M. Sale, D.S. Siscovick, J.I. Rotter,
S.S. Rich, J.D. Kaufman, Common genetic variation, residential proximity to traﬃc
exposure, and left ventricular mass: the multi-ethnic study of atherosclerosis,
Environ. Health Perspect. 118 (7) (2010) 962–969.
[112] A. Dominguez-Rodriguez, S. Rodriguez, P. Abreu-Gonzalez, P. Avanzas,
R.A. Juarez-Prera, Black carbon exposure, oxidative stress markers and major
adverse cardiovascular events in patients with acute coronary syndromes, Int J.
Cardiol. 188 (2015) 47–49.
[113] S. Weichenthal, E. Lavigne, G. Evans, K. Pollitt, R.T. Burnett, Ambient PM2.5 and
risk of emergency room visits for myocardial infarction: impact of regional PM2.5
oxidative potential: a case-crossover study, Environ. Health 15 (1) (2016) 46.
[114] C.S. Weldy, Y. Liu, H.D. Liggitt, M.T. Chin, In utero exposure to diesel exhaust air
pollution promotes adverse intrauterine conditions, resulting in weight gain, al-
tered blood pressure, and increased susceptibility to heart failure in adult mice,
PLoS One 9 (2) (2014) e88582.
[115] R.S. Perepu, D.E. Dostal, C. Garcia, R.H. Kennedy, R. Sethi, Cardiac dysfunction
subsequent to chronic ozone exposure in rats, Mol. Cell Biochem. 360 (1–2) (2012)
339–345.
[116] R. Sethi, S. Manchanda, R.S. Perepu, A. Kumar, C. Garcia, R.H. Kennedy,
S. Palakurthi, D. Dostal, Diﬀerential expression of caveolin-1 and caveolin-3: po-
tential marker for cardiac toxicity subsequent to chronic ozone inhalation, Mol.
Cell Biochem. 369 (1–2) (2012) 9–15.
[117] S. Mahne, G.C. Chuang, E. Pankey, L. Kiruri, P.J. Kadowitz, B. Dellinger,
K.J. Varner, Environmentally persistent free radicals decrease cardiac function and
increase pulmonary artery pressure, Am. J. Physiol. Heart Circ. Physiol. 303 (9)
(2012) (H1135-42).
[118] R.S. Perepu, C. Garcia, D. Dostal, R. Sethi, Enhanced death signaling in ozone-
exposed ischemic-reperfused hearts, Mol. Cell Biochem. 336 (1–2) (2010) 55–64.
[119] G. Meyer, L. Andre, S. Tanguy, J. Boissiere, C. Farah, F. Lopez-Lauri, S. Gayrard,
S. Richard, F. Boucher, O. Cazorla, P. Obert, C. Reboul, Simulated urban carbon
monoxide air pollution exacerbates rat heart ischemia-reperfusion injury, Am. J.
Physiol. Heart Circ. Physiol. 298 (5) (2010) H1445–H1453.
[120] G. Meyer, L. Andre, A. Kleindienst, F. Singh, S. Tanguy, S. Richard, P. Obert,
F. Boucher, B. Jover, O. Cazorla, C. Reboul, Carbon monoxide increases inducible
NOS expression that mediates CO-induced myocardial damage during ischemia-
reperfusion, Am. J. Physiol. Heart Circ. Physiol. 308 (7) (2015) H759–H767.
[121] M. Dianat, E. Radmanesh, M. Badavi, S.A. Mard, G. Goudarzi, Disturbance eﬀects
of PM on iNOS and eNOS mRNA expression levels and antioxidant activity induced
by ischemia-reperfusion injury in isolated rat heart: protective role of vanillic acid,
Environ. Sci. Pollut. Res. Int. 23 (6) (2015).
[122] F.M.A. Pereira, L.A.A. Pereira, F.F. Arbex, M. Arbex, G.M. Conceição, U.P. Santos,
A.C. Lopes, P.H.N. Saldiva, A.L.F. Braga, S. Cendon, Eﬀect of air pollution on
diabetes and cardiovascular diseases in São Paulo, Brazil, Brazillian J. Med. Biol.
Res. 41 (2008) 526–532.
[123] M.S. O'Neill, A. Veves, A. Zanobetti, J.A. Sarnat, D.R. Gold, P.A. Economides,
E.S. Horton, J. Schwartz, Diabetes enhances vulnerability to particulate air pol-
lution-associated impairment in vascular reactivity and endothelial function,
Circulation 111 (22) (2005) 2913–2920.
[124] A. Zanobetti, J. Schwartz, Are diabetics more susceptible to the health eﬀects of
airborne particles? Am. J. Respir. Crit. Care Med. 164 (2001) 831–833.
[125] S.K. Park, A.H. Auchincloss, M.S. O'Neill, R. Prineas, J.C. Correa, J. Keeler,
R.G. Barr, J.D. Kaufman, A.V. Diez Roux, Particulate air pollution, metabolic
syndrome, and heart rate variability: the multi-ethnic study of atherosclerosis
(MESA), Environ. Health Perspect. 118 (10) (2010) 1406–1411.
[126] K.A. Miller, D.S. Siscovick, L. Sheppard, K. Sheppard, J.H. Sullivan, G.L. Anderson,
J.D. Kaufman, Long-term exposure to air pollution and incidence of cardiovascular
events in women, N. Engl. J. Med. 356 (2007) 447–458.
[127] R.C. Puett, J. Schwartz, J.E. Hart, J.D. Yanosky, F.E. Speizer, H. Suh, C.J. Paciorek,
L.M. Neas, F. Laden, Chronic particulate exposure, mortality, and coronary heart
disease in the nurses' health study, Am. J. Epidemiol. 168 (10) (2008) 1161–1168.
[128] B. M, Biochemistry and molecular cell biology of diabetic complications, Nature
414 (2001) 813–820.
[129] U. Hink, H. Li, H. Mollnau, M. Oelze, E. Matheis, M. Hartmann, M. Skatchkov,
F. Thaiss, R.A.K. Stahl, A. Warnholtz, T. Meinertz, K. Griendling, D.G. Harrison,
U. Forstermann, T. Munzel, Mechanisms underlying endothelial dysfunction in
diabetes mellitus, Circ. Res. 88 (2001) e14–e22.
[130] M.S. O'Neill, A. Veves, J.A. Sarnat, A. Zanobetti, D.R. Gold, P.A. Economides,
E.S. Horton, J. Schwartz, Air pollution and inﬂammation in type 2 diabetes: a
mechanism for susceptibility, Occup. Environ. Med. 64 (6) (2007) 373–379.
[131] P.W. Franks, R.L. Hanson, W.C. Knowler, M.L. Sievers, P.H. Bennett, H.C. Looker,
Childhood obesity, other cardiovascular risk factors, and premature death, N.
Engl. J. Med. 362 (6) (2010) 485–493.
[132] N. Mattsson, T. Ronnemaa, M. Juonala, J.S. Viikari, O.T. Raitakari, Childhood
predictors of the metabolic syndrome in adulthood. The cardiovascular risk in
Young Finns Study, Ann. Med 40 (7) (2008) 542–552.
[133] J.H. Kim, Y.C. Hong, GSTM1, GSTT1, and GSTP1 polymorphisms and associations
between air pollutants and markers of insulin resistance in elderly Koreans,
Environ. Health Perspect. 120 (10) (2012) 1378–1384.
[134] Y.C. Huang, M. Schmitt, Z. Yang, L.G. Que, J.C. Stewart, M.W. Frampton,
R.B. Devlin, Gene expression proﬁle in circulating mononuclear cells after ex-
posure to ultraﬁne carbon particles, Inhal. Toxicol. 22 (10) (2010) 835–846.
[135] Z. Xu, X. Xu, M. Zhong, I.P. Hotchkiss, R.P. Lewandowski, J.G. Wagner,
L.A. Bramble, Y. Yang, A. Wang, J.R. Harkema, M. Lippmann, S. Rajagopalan,
L.C. Chen, Q. Sun, Ambient particulate air pollution induces oxidative stress and
alterations of mitochondria and gene expression in brown and white adipose tis-
sues, Part Fibre Toxicol. 8 (2011) 20.
[136] L. Sun, C. Liu, X. Xu, Z. Ying, A. Maiseyeu, A. Wang, K. Allen, R.P. Lewandowski,
L.A. Bramble, M. Morishita, J.G. Wagner, J. Dvonch, Z. Sun, X. Yan, R.D. Brook,
S. Rajagopalan, J.R. Harkema, Q. Sun, Z. Fan, Ambient ﬁne particulate matter and
ozone exposures induce inﬂammation in epicardial and perirenal adipose tissues
in rats fed a high fructose diet, Part Fibre Toxicol. 10 (2013) 43.
[137] X. Xu, Z. Yavar, M. Verdin, Z. Ying, G. Mihai, T. Kampfrath, A. Wang, M. Zhong,
M. Lippmann, L.C. Chen, S. Rajagopalan, Q. Sun, Eﬀect of early particulate air
pollution exposure on obesity in mice: role of p47phox, Arterioscler Thromb. Vasc.
Biol. 30 (2010) 2518–2527.
[138] P. Haberzettl, T.E. O'Toole, A. Bhatnagar, D.J. Conklin, Exposure to ﬁne particu-
late air pollution causes vascular insulin resistance by inducing pulmonary oxi-
dative stress, Environ. Health Perspect. 124 (12) (2016) H1423–H1438.
[139] Y. Wei, J.J. Zhang, Z. Li, A. Gow, K.F. Chung, M. Hu, Z. Sun, L. Zeng, T. Zhu,
G. Jia, X. Li, M. Duarte, X. Tang, Chronic exposure to air pollution particles in-
creases the risk of obesity and metabolic syndrome: ﬁndings from a natural ex-
periment in Beijing, FASEB J. 30 (6) (2016) 2115–2122.
[140] A. Nemmar, D. Subramaniyan, J. Yasin, B.H. Ali, Impact of experimental type 1
diabetes mellitus on systemic and coagulation vulnerability in mice acutely ex-
posed to diesel exhaust particles, Part Fibre Toxicol. 10 (2013) 14.
[141] R.E. Vella, N.J. Pillon, B. Zarrouki, M.L. Croze, L. Koppe, M. Guichardant,
S. Pesenti, M.A. Chauvin, J. Rieusset, A. Geloen, C.O. Soulage, Ozone exposure
triggers insulin resistance through muscle c-Jun N-terminal kinase activation,
Diabetes 64 (3) (2015) 1011–1024.
[142] J. Zhong, K. Allen, X. Rao, Z. Ying, Z. Braunstein, S.R. Kankanala, C. Xia, X. Wang,
L.A. Bramble, J.G. Wagner, R. Lewandowski, Q. Sun, J.R. Harkema,
S. Rajagopalan, Repeated ozone exposure exacerbates insulin resistance and ac-
tivates innate immune response in genetically susceptible mice, Inhal. Toxicol.
(2016) 1–10.
[143] A. Seaton, W. MacNee, K. Donaldson, D. Godden, Particle air pollution and acute
health eﬀects, Lancet 345 (1995) 176–178.
[144] K. Donaldson, V. Stone, A. Seaton, W. MacNee, Ambient particle inhalation and
the cardiovascular system: potential mechanisms, Environ. Health Perspect. 109
(Suppl 4) (2001) 523–527.
[145] A. Bhatnagar, Cardiovascular pathophysiology of environmental pollutants, Am. J.
Physiol. Heart Circ. Physiol. 286 (2004) H479–H485.
[146] Y. Mo, R. Wan, J. Wang, S. Chien, D.J. Tollerud, Q. Zhang, Diabetes is associated
with increased sensitivity of alveolar macrophages to urban particulate matter
exposure, Toxicology 262 (2) (2009) 130–137.
[147] Y. Zhang, Y. Mo, A. Gu, R. Wan, Q. Zhang, D.J. Tollerud, Eﬀects of urban parti-
culate matter with high glucose on human monocytes U937, J. Appl. Toxicol. 36
(4) (2015) 586–595.
[148] A. Zaky, A. Ahmad, L.J. Dell'Italia, L. Jahromi, L.A. Reisenberg, S. Matalon,
S. Ahmad, Inhaled matters of the heart, Cardiovasc, Regen. Med. 2 (2015).
[149] R.M. Damiani, M.O. Piva, M.R. Petry, P.H. Saldiva, A. Tavares Duarte de Oliveira,
C.R. Rhoden, Is cardiac tissue more susceptible than lung to oxidative eﬀects in-
duced by chronic nasotropic instillation of residual oil ﬂy ash (ROFA)? Toxicol.
Mech. Methods 22 (7) (2012) 533–539.
[150] V.M. Costa, F. Carvalho, J.A. Duarte, L. Bastos Mde, F. Remiao, The heart as a
target for xenobiotic toxicity: the cardiac susceptibility to oxidative stress, Chem.
Res Toxicol. 26 (9) (2013) 1285–1311.
[151] P. Kumarathasan, E. Blais, A. Saravanamuthu, A. Bielecki, B. Mukherjee,
F.J. Kelly, J.C. Fussell Free Radical Biology and Medicine 110 (2017) 345–367
366
S. Bjarnason, J. Guenette, P. Goegan, R. Vincent, Nitrative stress, oxidative stress
and plasma endothelin levels after inhalation of particulate matter and ozone, Part
Fibre Toxicol. 12 (2015) 28.
[152] B. Halliwell, Free radicals and antioxidants: updating a personal view, Nutr. Rev.
70 (5) (2012) 257–265.
[153] M.P. Murphy, A. Holmgren, N.G. Larsson, B. Halliwell, C.J. Chang,
B. Kalyanaraman, S.G. Rhee, P.J. Thornalley, L. Partridge, D. Gems, T. Nystrom,
V. Belousov, P.T. Schumacker, C.C. Winterbourn, Unraveling the biological roles
of reactive oxygen species, Cell Metab. 13 (4) (2011) 361–366.
[154] M.D. Evans, V. Mistry, R. Singh, D. Gackowski, R. Rozalski, A. Siomek-Gorecka,
D.H. Phillips, J. Zuo, L. Mullenders, A. Pines, Y. Nakabeppu, K. Sakumi,
M. Sekiguchi, T. Tsuzuki, M. Bignami, R. Olinski, M.S. Cooke, Nucleotide excision
repair of oxidised genomic DNA is not a source of urinary 8-oxo-7,8-dihydro-2'-
deoxyguanosine, Free Radic. Biol. Med. 99 (2016) 385–391.
[155] B. Halliwell, Free radicals and antioxidants – quo vadis? Trends Pharmacol. Sci. 32
(3) (2011) 125–130.
[156] G. Wang, L. Zhen, P. Lu, R. Jiang, W. Song, Eﬀects of ozone and ﬁne particulate
matter (PM2.5) on rat cardiac autonomic nervous system and systemic in-
ﬂammation, Wei Sheng Yan Jiu 42 (4) (2013) 554–560.
F.J. Kelly, J.C. Fussell Free Radical Biology and Medicine 110 (2017) 345–367
367
